Sigenergy Passes Hearing: “AI + Energy Storage” Driving a 150-fold Revenue Surge and Redefining Industry Growth ACN Newswire

Sigenergy Passes Hearing: “AI + Energy Storage” Driving a 150-fold Revenue Surge and Redefining Industry Growth

HONG KONG, Mar 30, 2026 - (ACN Newswire via SeaPRwire.com) - Sigenergy Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Sigenergy" or the "Company"), a leading global provider of AI-native solar-storage-charging solutions, officially passed its listing hearing with the Hong Kong Stock Exchange (HKEX) today.A spiring to be the "Apple of the Energy World," Sigenergy has reshaped the energy product ecosystem with "AI + Energy Storage" at its core. By positioning AI as the underlying capability permeating product design, system operation, and user interaction, the Company has achieved a leap from "manufacturing" to an "intelligent system platform." Leveraging disruptive AI product power and a precise global high-end strategy, the Company has demonstrated extraordinary growth momentum: revenue surged over 150-fold within two years, and the gross margin for 2025 exceeded 50%, showcasing a new paradigm of "value-driven growth" to the capital market.Revenue Grew 150-fold in Two Years; Profitability Ranks Among the Top in the IndustryAccording to the latest data disclosed in the prospectus, Sigenergy's revenue scale has demonstrated extreme growth momentum. As of December 31, 2025, the Company’s operating revenue soared from RMB 58 million in 2023 to RMB 9 billion in 2025, achieving an astonishing growth of over 150-fold within two years.While achieving rapid expansion in revenue scale, the Company's profitability has also significantly improved. Its gross margin rose steadily from 31.3% in 2023 to 50.1% in 2025, with an adjusted net margin as high as 35.9% in 2025. Both indicators rank among the top in the global distributed energy storage industry. This reflects that the Company has successfully broken away from the common low-price competition framework of the industry, enhanced its pricing power through technological advantages, and thereby achieved synergistic growth in both scale expansion and profitability levels.From "5-in-One" to Full-Scenario Coverage: Reshaping the Energy Management ParadigmSigenergy's core product, SigenStor, with its pioneering "5-in-one" design concept, has completely restructured the system morphology of distributed energy storage. SigenStor deeply integrates the solar inverter, power conversion system (PCS), battery pack, DC fast charging module, and energy management system (EMS) into a single platform. Through "AI + stackable" technology, users can flexibly expand system capacity as easily as building "LEGO" blocks. This highly integrated and extremely standardized system architecture optimizes the installation experience and provides the foundation for large-scale channel replication and global promotion.At the system level, the Company has achieved near 0-millisecond on/off-grid switching technology through hardware-software synergy and system control optimization. Compared to traditional backup power solutions, its "seamless switching" characteristic minimizes the impact of grid fluctuations or interruptions on end-user electricity consumption. This ensures the continuous operation of critical loads in residential scenarios and effectively avoids production and operational losses caused by instantaneous power outages in industrial and commercial (C&I) scenarios.On this basis, the Company has constructed a product portfolio covering residential, C&I, and large-scale utility power plants. In residential and C&I scenarios, the Company adopts modular, highly integrated, and scalable designs, enabling systems with flexible deployment and continuous upgrade capabilities. In utility-scale scenarios, the Company provides long-term value to customers centered on the concepts of "high yield, long-term safety and reliability, and simple O&M."This multi-scenario layout is built upon platform-based capabilities anchored in a unified technical foundation. Through integrated hardware-software design, a unified data architecture, and control logic, the Company has achieved technical synergy and capability reuse across different products and scenarios. This system enhances R&D efficiency and product iteration speed, providing the underlying support for the Company's global scale replication and long-term profitability."AI in All" Constructs a "Growth Flywheel", Driving a Fundamental Leap in Ecological ValueSigenergy adheres to the "AI in All" strategy, viewing AI as a fundamental capability permeating product design, system operation, and user interaction. At the critical juncture of the global energy transition toward intelligence and systematization, the Company is driving energy management from single-device control toward multi-device synergy and global optimization. In this way, dispersed devices, complex energy flows, and diverse application scenarios are integrated into a highly synergistic whole, empowering the entire energy system with unified dispatching and continuous evolution capabilities.Based on this strategy, all core products of Sigenergy have pre-allocated computing power, data interfaces, and control capabilities during the architectural design stage. Whether it is the SigenStor residential system, AC EV chargers, or C&I and utility-scale products, all can seamlessly access the AI ecosystem. This means the Company is building not just individual devices, but an AI-centric energy system capable of cross-scenario synergistic operation. The dimension of competition has upgraded from single-product performance to a comprehensive competition of system capabilities, ecological capabilities, and continuous evolution capabilities.The deeper value of AI capabilities lies in the formation of a "Growth Flywheel." As the number of globally deployed devices increases, while ensuring data security and user rights, the AI system continuously accumulates real-world operational data such as weather, electricity prices, power generation, loads, and user habits. This makes power consumption decisions more precise and system operations more efficient, thereby forming an ever-deepening ecological barrier.More importantly, this capability has directly translated into commercial value. In overseas high-end markets with dynamic electricity pricing, the AI system can assist users in optimizing power strategies to maximize energy economic benefits. Taking the Swedish market as an example, the system has helped users reduce their average electricity costs by approximately 70%, directly converting AI capabilities into "tangible economic returns" and creating incremental value that traditional products cannot provide. Leveraging its leading AI application capabilities, Sigenergy has achieved a fundamental leap from an "energy equipment manufacturer" to an "AI-centric energy system platform."Leading Global Market Share; Comprehensive Upgrade of Delivery CapabilitiesAs of December 31, 2025, the Company has established partnerships with 172 distributors and over 17,600 installers from 85 countries, covering core markets such as Europe, Asia-Pacific, North America, and Africa, and extending to emerging regions like Latin America, Central Asia, and South Asia. The Company has built a relatively sophisticated sales, service, and technical support network globally, laying a solid foundation for rapid localization in high-threshold markets and serving as the driving force for long-term growth.Against the backdrop of intensified industry competition, Sigenergy persists in a development path that combines high-end positioning with globalization. Through "strategic superiority" via technology—deeply integrating modular design, full-scenario integration, and AI dispatching algorithms—the Company effectively avoids homogenized competition and continuously enhances product added value. The prospectus shows that high-value markets such as Australia and Europe have become core pillars of the Company's business growth, with sales revenue ranking in the top two. In global benchmark markets with stringent requirements for product performance and safety, according to market reports from the Australian energy consultancy SunWiz, Sigenergy ranked first in market share for systems under 1,000kWh in Australia, Ireland, and South Africa in 2025; it also holds leading positions in markets such as the UK, Sweden, and the Benelux region. This series of market performances fully validates the Company's strong brand premium and commercialization capabilities in high-end market segments.To support global expansion, the Company has constructed three major manufacturing bases centered in Shanghai Lingang, Jinqiao, and Nantong, Jiangsu. Among them, the Nantong Smart Energy Center officially commenced production in the first quarter of 2026, with a total investment of RMB 500 million and a total construction area of 136,000 square meters. With an annual capacity exceeding 300,000 inverters and battery PACKs, it is one of the world's largest single-unit distributed energy storage factories. Through a synergistic system of "advanced manufacturing bases + intelligent industrial systems + deep AI empowerment," the Company has not only achieved the rapid release of large-scale capacity but also built high-consistency and high-reliability global delivery capabilities, forming a critical manufacturing barrier against competitors.For this Hong Kong listing, the Company intends to use the proceeds for R&D investment, global sales network expansion, and intelligent manufacturing upgrades. Following the successful passing of the hearing, Sigenergy will continue to leverage its "AI-native" technological advantages, driving the industry's transition from traditional equipment competition to a comprehensive transformation defined by AI-driven systems, ecosystems, and long-term value.For inquiries, please contact:EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITEDMs. Claire ZhangTel: (852)3468 8171 Email: project_alps.list@everbloom.com.cn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
S CUBE Capital Fund Ranked No. 1 Fixed Income Performer in Asia Pacific by Bloomberg ACN Newswire

S CUBE Capital Fund Ranked No. 1 Fixed Income Performer in Asia Pacific by Bloomberg

Singapore, Mar 30, 2026 - (ACN Newswire via SeaPRwire.com) - S CUBE Capital’s Fixed Income Tactical Opportunities Fund II, managed by the Singapore-based investment manager specializing in Global and Indian strategies, has been ranked by Bloomberg as the top-performing USD fixed income fund. The firm outperformed strategies managed by leading global institutions across a universe of funds spanning 15 Asia Pacific markets including Singapore, Hong Kong, India, China, Japan, Korea, Taiwan, Australia and Mauritius.Over the one-year period ending January 31, 2026, Bloomberg reported that FITOF – Fund II delivered total returns of 12.44%, outperforming its nearest peer by more than 200 basis points. This recognition follows a similar distinction received by S CUBE two years ago and underscores the strength of the firm’s investment framework, as well as its deep expertise in navigating global credit markets. While the fund remains focused on high-quality bonds, its positioning has maintained a meaningful overweight to Indian credits, reflecting strong conviction in the country’s macroeconomic trajectory.Commenting on the performance, Hemant Mishr, Founder and CIO, S CUBE Capital, said "We are delighted to receive this recognition – it is particularly special as it marks our second such recognition in the past three years and comes against a backdrop of heightened geopolitical risk and a challenging macroeconomic environment. To be acknowledged alongside such a strong cohort of global funds is a testament to the strength of our team and the rigor of our investment framework.“We are seeing strong investor interest supported by favourable tailwinds. A change of guard at the US Fed is reinforcing expectations of a more dovish monetary policy. At the same time rising stress in the private credit market is likely to catalyse a rotation of capital towards public credit strategies- an area where we are well positioned to capture attractive risk-adjusted opportunities” adds Hemant."Balaji Swaminathan, Founder and CEO, S CUBE Capital added “We are pleased to be recognized once again for delivering consistent returns for our investors. Our focus remains on combining rigorous credit selection with deep on-the-ground insights to capture opportunities across Asia and our overweight position in Indian dollar issuers has been a key driver of our performance. As India’s role in the global economy continues to strengthen, we believe our platform is well positioned to connect international investors with high-quality credit opportunities in the region”.About S CUBE CapitalS CUBE is a global fund management company domiciled in Singapore and regulated by the Monetary Authority of Singapore (MAS). We are a strong and dedicated team of internationally experienced experts delivering institutional investment expertise to client. Our team has managed investments of over USD 50 billion in our previous roles and has a cumulative experience of over 100 years in Global Financial Markets across assets including Credit, Equities, Fixed Income, Rates, FX and Commodities. For more information visit https://scubecapital.com/.Media contact:Namrata Sharma+65 81383034Namrata.sharma@adfactorspr.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut

Haitian Flavouring Releases 2025 Annual Results: Multi-Dimensional Category Growth + Accelerated Globalization – High-Quality Growth Highlights Long-Term Value

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - Condiments are an important carrier of Chinese culinary culture, playing an irreplaceable role in people’s daily diet, the upgrading of the catering industry, and the development of the food industry. As the absolute leader in the condiment industry, Foshan Haitian Flavouring & Food Co., Ltd. (A-share: 603288; H-share: 03288) delivered a high-quality performance report in 2025, leveraging its comprehensive product portfolio, leading digital and intelligent capabilities, and resolute internationalization strategy. The company continues to lead the industry and stands as a well-deserved industry benchmark.On 26th March, Haitian Flavouring released its 2025 annual report. Financial data shows that in 2025, the company achieved total revenue of RMB 28.873 billion, a year-on-year increase of 7.32%. Profitability improved simultaneously, with full-year net profit attributable to shareholders of the parent company reaching RMB 7.038 billion, up 10.95% year-on-year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses amounted to RMB 6.845 billion, a year-on-year rise of 12.81%, and the gross profit margin of its core condiment business reached 41.78%, representing a year-on-year increase of 3.15 percentage points. All operating data hit record highs, demonstrating strong development resilience and core competitiveness, and further widening the gap with industry peers.Product Matrix Diversification: Building a Foundation for Multi-Dimensional GrowthAs a time-honored Chinese enterprise with a 400-year history deeply rooted in the condiment industry, Haitian Flavouring has built a stable and resilient multi-dimensional growth pattern through its continuously enriched product portfolio for the mass market, with its core product categories maintaining a globally leading competitive position.In the soy sauce category, Haitian Flavouring has always adhered to a consumer-centric approach. Focusing on consumers’ diverse needs, the company has continuously innovated in flavor, functionality, and specifications, establishing a complete product matrix covering both basic mass consumption and various segmented scenarios. Its product lines include not only classic series, premium soy sauce series, and time-honored series for daily cooking, but also healthy and nutritious lines such as organic, less-sodium, iron-fortified, selenium-enriched, and gluten-free products, as well as trendy products such as matsutake premium soy sauce.In the oyster sauce category, the company insists on selecting premium whole oysters from high-standard marine ranches and simmering them into sauce. With genuine ingredients and rigorous craftsmanship, Haitian oyster sauce maintains its advantage of being “rich in flavor, free from any fishy taste; one simple step to seal in freshness” . Currently, the company has launched diversified products such as Haitian superior oyster sauce and golden label oyster sauce, covering different flavors, packaging specifications, and price points. In response to consumer demand, the company has carried out scenario-based innovation, successively launching new products such as spicy oyster sauce and matsutake fresh oyster sauce to continuously enrich consumer choices.In the seasoning sauce category, the company’s products are mainly divided into two categories: basic flavored sauces and compound flavored sauces. It has built a product system with rich categories, diverse flavors, and multiple scenarios, such as Chu Hou Paste, Hoisin Sauce, Sauce for Rice, and Mushroom Sauce, which are suitable for different cooking methods. Meanwhile, the company adheres to a dual-wheel layout of “traditional vinegar + specialty vinegar,” developing regional characteristic rice vinegar such as sweet rice vinegar, selected fresh rice vinegar, and kangle vinegar, as well as specialty fruit vinegar including sugar-free apple cider vinegar and raw orange vinegar. This has formed a rich and diverse vinegar product system, further consolidating the company’s all-category competitive advantages, providing solid support for its steady performance growth, and building a profound market barrier.Benefiting from the recovery of the consumer market and its extensive product portfolio, Haitian Flavouring’s core categories including soy sauce, oyster sauce, and seasoning sauces maintained steady development in 2025, achieving operating revenues of RMB 14.934 billion, RMB 4.868 billion, and RMB 2.917 billion respectively, with year-on-year growth rates of 8.55%, 5.48%, and 9.29%. The three major categories maintained positive growth simultaneously, providing solid support for the overall performance.As of the end of 2025, Haitian Flavouring has established 7 product series each generating over RMB 1 billion in revenue, and more than 30 product series each exceeding RMB 100 million, with product concentration and competitiveness continuing to improve. Among them, the two products series of Golden Label Light Soy Sauce and Mushroom Dark Soy Sauce have been bestsellers for over 60 years. The two products series of Premium Soy Sauce and Haitian Superior Oyster Sauce have achieved annual revenue of over RMB 1 billion per product for over 10 consecutive years, becoming the core drivers supporting the Company's steady performance growth and demonstrating strong product vitality and high market recognition.While consolidating its advantages in core product categories, Haitian Flavouring proactively adapts to the trend of consumption upgrading, invests heavily in new product development, creates trend-setting new products, and forms a continuously evolving growth flywheel. Supported by its industry-leading product strength, the nutritionally healthy product series, represented by organic and less-sodium options, achieved operating revenue with a year-on-year growth rate of 48.3%, significantly outperforming the industry average growth rate and opening up a new growth curve for the Company's performance growth.Furthermore, Haitian Flavouring is proactively transforming itself from a "condiments supplier" to a "comprehensive flavor solutions provider," accurately capturing the new market opportunities brought by the industrialization and chain-upgrading of the catering industry. As of the end of 2025, the Company has cumulatively provided one-stop commercial condiment solutions to catering chains, food enterprises, and numerous global retail brands, further expanding its profit margins.Meanwhile, the Company boasts leading digitalization-enabled flexible production and customized service capabilities. It can produce up to over 20 specifications and more than 130 SKUs of different products on the same production line, with its customized service response and time-to-market speed leading the industry. Powered by its digital transformation, the Company's ultimate supply chain has established a new paradigm for the collaborative development of "customization, scale, quality-to-price performance ratio" in the manufacturing industry. This not only ensures stable and safe product quality to meet the stringent requirements of chain catering but also caters to the diverse needs of different users for condiments.Digitalization Empowers Across the Entire Chain, Technological Innovation Boosts EfficiencyTechnology development and technological innovation are the core engines driving Haitian Flavouring's performance growth. The Company proactively embraces the AI era, deeply integrating artificial intelligence and big data into the entire chain of R&D, production, supply, and sales. This promotes the organic integration of cutting-edge digital technologies with millennia-old brewing techniques, achieving a comprehensive leap in production efficiency, product quality, and operational effectiveness.Every year, Haitian maintained R&D investment at approximately 3% of its operating revenue, solidifying the foundation for innovation with a long-term perspective. Meanwhile, the Company’s Gaoming production base was successfully recognized as the world's first "Lighthouse Factory" in the soy sauce brewing industry, a benchmark for smart manufacturing certified by the World Economic Forum, redefining the Digitalization height of the traditional condiments industry.With comprehensive digital empowerment, Haitian's supply chain operational efficiency has significantly improved. In 2025, the Company's On-Time In-Full (OTIF) delivery rate continued to optimize, and customer service levels reached a new height. At the same time, the ratios of manufacturing expenses and direct labor costs to operating costs-two core cost indicators- surpassed those of most peers, achieving a dual breakthrough in quality improvement, efficiency enhancement, and cost control.Thanks to its outstanding digital practices, in 2025, the Company won numerous awards, including the "CGF China Supply Chain Digitalization and Sustainable Resilience Development Case" and the "National Typical Cases of Digital Transformation in Manufacturing", establishing itself as a benchmark for digital transformation in the industry. Additionally, the national standard " General Technical Requirements for Food Production Digital Factories", led by Haitian, was officially released. This fills the gap in the field of digital factory construction in China's food industry and provides authoritative and unified technical guidelines and an implementation framework for the Digitalization upgrading of the food industry.Leveraging smart technologies, the Company also achieved notable progress in green manufacturing. In terms of energy structure, the scale of solar photovoltaic power stations increased by nearly 100%, and a biomass power generation project was also put into operation. Power generated from green energy reached 29 million kWh, while the share of green electricity exceeded 28%. Through a smart water-saving system, the Company made dedicated efforts to set a benchmark in water conservation, recycling 1.88 million cubic meters of water over the past year, equivalent to the capacity of 752 standard swimming pools. In 2025, the Company implemented 128 energy-saving and carbon-reduction initiatives, these efforts resulted in a total reduction of 29,000 tonnes of carbon dioxide equivalent, marking a solid step forward in its green and low-carbon development.Accelerating Global Expansion, Charting a New Course on the World StageWhile maintaining its leading position and deepening its presence in the domestic market, Haitian Flavouring has been proactively expanding its international footprint and accelerating its pace to "set sail" for global markets. Adhering to a dual-track development approach of "global standards + local adaptation," the Company’s products are now sold in over 80 countries and regions worldwide. It has been named a "Chinese Brand Loved by Foreigners" for two consecutive years, reflecting its growing international influence and marking a transition from "product export" to "enterprise globalization."Recently, the Company successfully upgraded its British Retail Consortium (BRC) rating from Grade B to Grade A, a testament to its quality control system receiving internationally recognized accreditation and achieving a world-class standard. This accomplishment has instilled strong confidence in the Company’s efforts to further expand its global footprint and enter premium retail channels in Europe and the United States, while also underscoring the high quality and international competitiveness of Haitian’s products.On March 17, the Company was recognized as a Leading Enterprise in the 2026 Forbes China Pioneer Innovators in Industry Development Selection in recognition of its digital and intelligent transformation as well as its green development practices, affirming the Company’s long-term value creation.In June 2025, the Company was successfully listed on the Hong Kong Stock Exchange, marking a new milestone as it now operates on the dual A+H share platform. The listing attracted eight prominent domestic and international institutions, including Hillhouse Capital and the Government of Singapore Investment Corp (GIC), to serve as cornerstone investors, underscoring the international market's recognition of the Company's growth potential and providing ample capital to support its global expansion strategy. In the same year, the Company also established its overseas production base, further enhancing its global production and sales network. This provides a solid foundation for building a global supply chain and leveraging the Company's competitive advantages from the domestic market, marking a critical step forward in the execution of its internationalization strategy.On the brand development front, the Company continues to deepen its commitment to “400-Year Legacy of Oriental Flavor” Through iconic IPs such as Chef of China, it has captured widespread attention across Mainland China, Hong Kong, Macao, Taiwan, and beyond, creating a deep resonance between traditional brewing culture and modern consumer experiences. In addition, the Company launched the “Ambassador for Chinese Flavor” Initiative, bringing together collaborators to ignite global enthusiasm for authentic Chinese cuisine.Overall, in 2025, Haitian Flavouring delivered an impressive performance, driven by its steady operations and forward-looking strategy. Building on a comprehensive product matrix and leveraging digital empowerment, the Company has successfully achieved a strategic transformation through in-depth, full-channel operations. This has enabled it to establish a core competitive edge capable of withstanding market volatility and navigating industry cycles.Looking ahead, the Company will continue to uphold its dedication to craftsmanship and innovation, further consolidate its leading position in the domestic market, and steadily accelerate its global expansion. By doing so, it aims to support the high-quality development of the traditional condiment industry, bring the taste of China to the world, and continue to lead the industry toward a new era of higher quality. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Shoucheng Holdings (0697.HK) Reports Approximately 37% Year-on-Year Growth in Industrial Fund Revenue, with Its Dual-Core Businesses Opening Up New Space for Earnings Realization ACN Newswire

Shoucheng Holdings (0697.HK) Reports Approximately 37% Year-on-Year Growth in Industrial Fund Revenue, with Its Dual-Core Businesses Opening Up New Space for Earnings Realization

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - The 2025 annual report of Shoucheng Holdings (0697.HK) sends a clear signal: the company is entering what it describes as its “best period in history.” The key to this assessment lies not merely in the growth of a single business segment, but in the fact that, after eight years of continuous transformation, Shoucheng Holdings has established a dual-engine core business model of “industrial funds + asset management” and is now entering a new phase of accelerated earnings realization.In his Chairman’s Statement, Chairman Zhao Tianyang noted that over the past eight years, the company has completed a continuous evolution from the divestment of non-performing assets and the injection of high-quality assets, to asset restructuring, deep industrial cultivation, and finally the realization of returns. Today, the company is steadily entering a stage of medium-to-high-speed growth. This also means that Shoucheng Holdings has moved beyond its earlier restructuring-and-recovery logic and into a new cycle marked by clear core businesses, a mature business model, and accelerating value release.From a business framework perspective, “industrial funds + asset management” has become the company’s most important growth engine. The former is responsible for value discovery, project investment, and securing high-quality assets, while the latter is responsible for operational efficiency enhancement, cash flow accumulation, and asset appreciation. Together, they form a closed-loop model spanning investment, operation, and exit, giving the company stronger earnings stability and greater certainty of future growth.Among these businesses, the industrial fund segment has delivered particularly strong growth. In 2025, revenue related to the company’s industrial fund business reached approximately HKD 402 million, representing a year-on-year increase of about 37%. This shows that the segment has moved beyond a single management-fee model and entered a new phase driven by a dual engine of “management fees + investment returns.” At the same time, the company is advancing the launch of two core funds: a strategic emerging and future industries fund, and a special fund for asset restructuring, with its fund matrix continuing to expand.The asset management business has further strengthened the company’s earnings foundation. In 2025, Shoucheng Holdings assisted in the issuance of seven publicly offered REITs and served more than 20 projects, corresponding to a total issuance scale of over RMB 100 billion. The company also continued to expand its presence in technology parks, consumer infrastructure, data centers, and clean energy. In its static transportation business, the company has promoted an upgrade from a single parking-fee model to diversified commercial revenue generation. Innovative business revenue accounted for 20% of the segment, while revenue yield per parking space increased by 17%, demonstrating the company’s ability to achieve both stable cash flow and asset appreciation.Overall, what is most noteworthy about Shoucheng Holdings at present is not just its earnings growth itself, but the fact that its dual-core businesses of “industrial funds + asset management” have formed a complete closed loop, and the company is now moving from “completing transformation” to “realizing value.” The phrase “best period in history” is the most fitting testament to this pivotal leap forward. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
From Parking Fees to ‘Mother Port’ Services for Autonomous Vehicles, Shoucheng Holdings (0697.HK) Is Rewriting the Business Model of Parking Lots ACN Newswire

From Parking Fees to ‘Mother Port’ Services for Autonomous Vehicles, Shoucheng Holdings (0697.HK) Is Rewriting the Business Model of Parking Lots

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings (0697.HK) is redefining the commercial value of parking lots. According to information released in the company’s 2025 annual report, parking lots are no longer merely static spaces that rely on parking fees for profit. Instead, they are being upgraded into intelligent digital infrastructure nodes serving Robotaxis, Robovans, and even eVTOL aircraft. Shoucheng uses the term “mother port” to describe this transformation, meaning that parking lots in the future will do far more than provide parking spaces. They will also support charging, berthing, maintenance, dispatching, automatic docking, and other back-end support services, becoming critical hubs in autonomous mobility systems.This shift is, in essence, a rewriting of the business model. Traditional parking lots mainly depend on time-based parking fees. Under Shoucheng’s E Park model, however, revenue streams are expanding to include dispatch service fees for autonomous vehicles, charging, battery swapping, and hosting fees for robots, maintenance and OTA service fees, commercial display and advertising revenue, and intelligent business integration income. Accordingly, the core assets of a parking lot are no longer limited to the number of parking spaces, but now also include site resources, intelligent platforms, charging and battery-swapping facilities, dispatching capabilities, and ecosystem support capabilities for autonomous operations.Behind this transformation lies a change in the commercialization logic of the autonomous driving industry. In the past, the sector focused more on whether vehicles could operate on the road. Today, the key factors determining operating efficiency are increasingly concentrated in back-end functions such as charging, berthing, maintenance, and dispatching. Where vehicles go to recharge after completing orders, where they park during off-peak hours, how faults are handled, and how cross-regional fleets are deployed efficiently now determine not only whether a single vehicle can be put on the road, but also whether an entire fleet can sustain operations and scale up. For this reason, parking lots are no longer the end point of the mobility chain; they are becoming the starting point of the next round of operations.Shoucheng’s unique advantage lies in its strong ability to integrate site resources and drive industrial synergies. Through models such as PPP and BOT, the company has long acquired operating rights and concession rights, with business coverage spanning airports, healthcare, public services, and other diversified scenarios, giving it the foundation to build a city-level node network. At the same time, Shoucheng also has a dual-engine capability combining industrial funds and asset operations. On one end, it is strategically positioned in embodied intelligence and robotics; on the other, it upgrades static transportation sites, enabling parking lots to more smoothly accommodate the emerging needs of the autonomous driving and robotics industries.In terms of implementation, this model has already begun to prove itself. Shoucheng has advanced robotics applications in relevant scenarios at Terminal 3 of Beijing Capital International Airport, and together with Wisson Robotics, it has built a demonstration project featuring robots and automatic charging at the Chengdu ICD project, promoting the extension of underground parking lots from single-purpose parking spaces to intelligent operational scenarios featuring integrated parking and charging. This shows that the “mother port” model is not just a concept, but is gradually moving toward practical application.It is foreseeable that in the future, the key to competition among parking lots will no longer be simply the number of parking spaces or parking turnover rates, but rather who can connect dispersed nodes into a citywide service network covering charging, berthing, operations and maintenance, and dispatching needs. What Shoucheng Holdings is betting on is no longer just parking fee income, but a more imaginative entry point into downstream service infrastructure in the era of autonomous mobility. For Shoucheng, parking is not the destination; “mother port services” are the real starting point of its new business model. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Shoucheng Holdings (697.HK) Sees an Inflection Point Approaching for REITs and Plans to Substantially Scale Up Investment in 2026 ACN Newswire

Shoucheng Holdings (697.HK) Sees an Inflection Point Approaching for REITs and Plans to Substantially Scale Up Investment in 2026

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings (697.HK) is accelerating the build-out of its end-to-end REITs platform. In 2025, the company recorded investment income of HKD 222 million in this segment, along with dividend income of HKD 54.075 million, for a combined total of approximately HKD 276 million, representing about 19.2% of total revenue. This business has gradually become an important source of profit.At the same time, the company partnered with China Life to establish a REITs stabilization fund with a total size of RMB 10 billion, further extending its reach into capital allocation and strengthening its closed-loop capabilities across investment, management, operation, and exit. As the business continues to deepen, Shoucheng Holdings is simultaneously advancing allocations to existing REITs and building reserves of incremental infrastructure assets, thereby continuously enhancing its capabilities in asset sourcing, operational synergies, and capital operations.In his Chairman’s Statement, Chairman Zhao Tianyang assessed that the infrastructure asset market is now approaching an “inflection point.” Following the earlier price correction, the company will comprehensively scale up investment in 2026, continue to actively position itself around high-quality infrastructure assets and REITs opportunities, and seize the next market window. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Behind the Fourfold Growth of the Beijing Robotics Fund in Four Years: Shoucheng Holdings (0697.HK) Locks In Its Position at the Infrastructure Gateway for Robotics Commercialization ACN Newswire

Behind the Fourfold Growth of the Beijing Robotics Fund in Four Years: Shoucheng Holdings (0697.HK) Locks In Its Position at the Infrastructure Gateway for Robotics Commercialization

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - Against the backdrop of continued momentum in humanoid robots and embodied intelligence, Shoucheng Holdings (0697.HK) is rapidly gaining market attention for its expanding presence in the robotics sector. According to the latest 2025 Chairman’s Statement, the Beijing Robotics Industry Development Investment Fund, which the company co-manages, has achieved approximately fourfold growth in portfolio valuation over the past four years, demonstrating strong capabilities in deal sourcing and value realization. At the same time, Shoucheng Holdings has invested in more than 20 leading companies in embodied intelligence and robotics, covering multiple areas including humanoid robots, quadruped robots, medical robotics, and the low-altitude economy, gradually building a relatively comprehensive industry footprint.Based on disclosed projects, the company’s investment portfolio already includes a number of representative enterprises such as Unitree Robotics, Galbot, Xinghaitu, TowardPi Medical, Volant, and DEEP Robotics. Management has also previously disclosed that the funds under the company’s management have cumulatively invested more than RMB 2 billion in the robotics industry, completing over 40 transactions. As the valuations of leading projects continue to rise and exit timelines gradually progress, Shoucheng Holdings is expected to unlock profits in the future through fund distributions, management fees, and carried interest.Taking Unitree Robotics, which has submitted a listing application, as an example, based on minimum post-offering dilution calculations, the value of the relevant equity stake held by the Beijing Robotics Fund has increased from approximately RMB 520 million to approximately RMB 1.55 billion, generating about RMB 1 billion in book value appreciation. This also reflects, from another angle, the return potential accumulated by Shoucheng Holdings through its forward-looking positioning in the robotics sector.In addition to investment returns, another differentiated advantage of Shoucheng Holdings lies in its ability to combine industrial investment with asset operation capabilities. Leveraging managed scenarios such as parking facilities, industrial parks, and airports, the company can provide portfolio robotics companies with support in product display, testing, energy replenishment, operations and maintenance, and commercialization deployment, gradually forming a closed-loop model of “investment + scenarios + operations.” This not only helps improve the deployment efficiency of portfolio companies, but also has the potential to enhance the utilization efficiency and commercial conversion capability of the company’s assets.In terms of shareholder returns, the company proposed a total dividend of HKD 780 million for 2025, corresponding to a dividend yield of approximately 5.6%. While continuing to increase its investment in robotics and embodied intelligence, Shoucheng Holdings has also demonstrated an operating profile that balances growth potential with shareholder returns. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut

China XLX Announces 2025 Annual Results Deepening efforts in reducing costs, enhancing efficiency, strengthening competitiveness through differentiation and driving marketing transformation

EQS via SeaPRwire.com / 29/03/2026 / 16:03 UTC+8 Press Release (For immediate release) China XLX Announces 2025 Annual Results Deepening efforts in reducing costs, enhancing efficiency, strengthening competitiveness through differentiation and driving marketing transformation 2025 Annual Results Highlights: Profit attributable to owners of the parent after deducting non-recurring items grew by 1.2% YoY to approximately RMB 932 million. Dividend payment increased by 23.1% YoY to RMB 32 fen per share. The ratio of long-term to short-term borrowings improved from 6:4 at the beginning of the year to 8:2 at the year end with finance cost dropped by 3% YoY. The Group’s liquidity and capital structure was thus further optimized. Development of the Xinxiang New Chemical Materials Project and the Zhundong Production Base progressed smoothly. The Group’s share in domestic fertiliser market is expected to grow by 6 percentage points upon the full operation of five production bases. (29 March 2026, Hong Kong) China XLX Fertiliser Ltd. (“China XLX” or the “Company”, together with its subsidiaries collectively referred to as the “Group”) (stock code: 01866.HK) announced that the Group’s revenue for the year ended 31 December 2025 grew by 9.6% year-on-year to approximately RMB 25.35 billion. Profit attributable to owners of the parent for the period amounted to approximately RMB 932 million, down by 36.1% year-on-year and up by 1.2% year-on-year if non-recurring items were deducted. In order to reward shareholders for their long-term support and to send a positive signal to the capital market, the Board of Directors, after comprehensive consideration of the Group’s actual operating performance and future strategic plans, proposed to distribute a final dividend of RMB 32 fen per share, up by 23.1% year-on-year. During the review period, the supply glut of domestic coal chemical-related market dragged down the selling prices of products and weighed on the industry’s overall operating results. The Group adhered to the core profitability model of “low cost + differentiation” and focused on “project development” and “marketing transformation”. While making continuous efforts in reducing costs and increasing efficiency, it reinforced the competitive edges through differentiation and advanced the strategy of marketing transformation, thereby ensuring the stable operation of overall business. During the review period, revenue from urea sales reached approximately RMB 6.83 billion, down by 6% year-on-year. Due to the decline in feedstock prices, urea selling price was sluggish in the first quarter and led to a 10% year-on-year decrease in the average selling price for the year. On the other hand, driven by relaxed export controls and the unleashing of demand for winter stockpiling, urea prices rebounded quarter by quarter afterwards. It is noteworthy that the selling price in the fourth quarter climbed by 3% from previous quarter. In order to mitigate the adverse impacts of declining prices, the Group fully capitalized on the opening of export window to expand overseas sales with a primary focus on increasing the proportion of exports to Southeast Asia. As a result, the urea export volume substantially grew, leading to a 3% year-on-year increase in urea sales volume for the year. Revenue from compound fertiliser sales amounted to approximately RMB 6.92 billion in the year, up by 15% year-on-year. In a market environment characterized by misalignment in price transmission, the Group leveraged its nationwide network of small-scale production bases to accelerate marketing transformation and to strengthen agrochemical services, resulting in a 19% year-on-year increase in the sales volume of compound fertiliser. Nevertheless, owing to the national policies to stabilize selling prices and supply, the transmission of feedstock costs to the product prices was delayed, creating a temporary operational pressure arising from “lower prices amid rising costs”. Besides, farmers delayed fertiliser stockpiling, leading to a 3% year-on-year decrease in the average selling price of compound fertiliser. Revenue from methanol sales in the year surged by 37% year-on-year to approximately RMB 3.67 billion. As domestic economy steadily picked up and the capacity utilization of chemical sector improved, the downstream demand for methanol gradually recovered. As a result, the sales volume of methanol jumped by 43% from the previous year. On the other hand, methanol imports from the Middle East climbed to a record high due to geopolitical tensions. The average selling price of methanol hence dropped by 4% year-on-year on ample supply in the market. With the successful commissioning of Jiujiang Phase II Project, the Group possessed more low-cost, high-quality production capacity. It became a benchmark for the Group’s development of large-scale project and capacity optimization plan. Meanwhile, the construction of the new chemical materials project at the Xinxiang Production Base and the Zhundong Production Base progressed as planned. When all of five major production bases come on stream, the Group’s share in domestic fertiliser market is expected to increase by 6 percentage points. Leveraging its large-scale synthetic ammonia production bases, the Group had established multiple small-scale compound fertiliser bases across the country. Benefiting from their proximity to end-user markets, the Group further strengthened the nationwide marketing network. In order to safeguard the financial security and ensure its stable operation, the Group promoted steady and orderly development of large-scale production bases and projects in accordance with the development strategy for next three years, with investment in new projects and new production bases increasing by approximately 24% year-on-year. At the same time, the Group continued to optimize the debt structure, strengthening its financial stability and ensuring the orderly development of projects through medium- and long-term low-cost financings. The Group further optimized the borrowing structure through the expansion of medium- and long-term financings. As a result, the ratio of long-term to short-term borrowings improved from 6:4 at the beginning of the year to 8:2 at the year end, thus further enhancing its liquidity and capital structure. During the period, the Group completed the replacement of high-interest loans worth approximately RMB 9.24 billion, including all prior high-interest financial lease loans. The borrowing interest rate thus reduced by 0.5 percentage point. While the Group continued to proceed with its development strategy and to increase the cash resources, its finance costs still dropped by 3% year-on-year. Looking ahead into 2026, Mr. Liu Xingxu, Chairman of China XLX, said: The general trend of domestic urea market for the year will see “ample supply, stable demand and export controls”. Despite the persistence of supply glut, the arable land area is expected to further expand under the support of national policy to ensure grain production. Therefore, agricultural demand is likely to grow. At the same time, the government is expected to further relax export controls and it cannot be ruled out that the export volume will be increased to optimize the demand and supply condition in the market. The imbalance condition of the urea market will see phasal improvement. All in all, the urea price for this year will remain stable, and the selling price is expected to grow steadily in the first half amid robust agricultural demand for farming peak season. Regarding project development, the trial run of the synthetic ammonia production facility at the Xinxiang New Chemical Materials Phase I Project (with capacity of 570,000 tons) goes smoothly. Most of its indicators perform well. Through energy-saving renovation of key equipment and optimization of production process, the project's production costs are expected to decrease by approximately 8% when compared with the Group's existing production facilities. Meanwhile, the development of the Zhundong Production Base Phase I is progressing steadily as planned and it is expected to be put into operation by the end of this year. With an access to local feedstocks, this project will enjoy significant benefits from low-cost feedstocks. Upon the commencement of its operation, the Group will reinforce the market leadership in terms of production capacity and energy efficiency, thereby laying a solid foundation for it to implement large-scale expansion and enhance its market competitiveness in the future. ~ END ~ About China XLX Fertiliser Ltd. China XLX Fertiliser Ltd. is one of the largest and most cost-efficient coal-based urea producers in China. It is principally engaged in developing, manufacturing and selling of urea, compound fertiliser, methanol, dimethyl ether, melamine, furfuryl alcohol, furfural, 2-methylfuran, pharmaceutical intermediates and related differentiated products. The Group adheres to the development strategy of “maintaining overall cost leadership and creating competitive differentiation" while strengthening the core fertiliser operations. With support of the resources in Xinxiang, Xinjiang and Jiangxi, it extends the value chain to upstream new energy and new materials and diversifies into coal chemical related products. The Company’s shares (stock code: 01866.HK) are traded on the main board of the Hong Kong Stock Exchange. Investor and Media Enquiries China XLX Fertiliser Ltd. Gui Lin Tel: 86-135-6942-3415 Email: gui.lin@chinaxlx.com.hk PRChina Limited David Shiu / Liky Guo Tel: 852-2522 1368 / 852-2522 1838 Email: dshiu@prchina.com.hk lguo@prchina.com.hk 29/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Lebih lanjut
From Parking Lots to Robot Hubs: Shoucheng Holdings (0697.HK) Redefines Static Transport Infrastructure Through Asset Management Logic ACN Newswire

From Parking Lots to Robot Hubs: Shoucheng Holdings (0697.HK) Redefines Static Transport Infrastructure Through Asset Management Logic

HONG KONG, Mar 28, 2026 - (ACN Newswire) - When a Robotaxi enters a parking structure, what it needs is no longer just a parking space, but a full infrastructure system to support its operations - including energy replenishment, dispatching, maintenance, data connectivity, and a complete fully autonomous end-to-end operational capability. For that reason, the underlying logic of the traditional parking lot is being redefined: it is no longer merely a static space for vehicle storage, but is rapidly evolving into a critical node for the operation of future unmanned systems.In its 2025 Annual Report, Shoucheng Holdings Limited (0697.HK) judged that parking lots will become the largest robot operating bases in the future. Zhao Tianyang, Chairman of the Board of Shoucheng Holdings, further explained the logic behind this view in the annual report: "What we see is not merely today's parking spaces, but the key nodes of future smart digital infrastructure." Based on this understanding, the role of the parking lot is changing - from a traditional supporting space for static transport to an infrastructure platform that supports robot operation, dispatch, and services.To understand this transformation, the key is to grasp the fundamental difference between the traditional parking model and the "E Park" model. Under the traditional model, parking lot revenue mainly comes from parking fees, the core asset is parking space resources, the main customers are vehicle owners, and the operating logic is essentially the management of space and time, with relatively limited growth potential. Under the E Park model, however, the parking lot is no longer a single space-leasing asset, but is upgraded into an integrated service platform for Robotaxis, Robovans, and various types of robots.This change is first reflected in the revenue structure. Revenue sources in the traditional parking business are relatively simple, whereas the E Park model can layer in multiple income streams, including dispatch service fees, charging or battery-swapping and custody fees, O&M and OTA service fees, advertising fees, and smart service integration fees, significantly broadening the boundaries of profitability. At the same time, the core assets of the parking lot are upgraded from mere parking space resources to a composite system of "site resources + energy-replenishment facilities + dispatching capabilities + robot access capabilities." In other words, the future value of a parking lot will no longer depend primarily on how many cars it accommodates, but on how deeply it can serve how many unmanned systems.The customer structure is also changing in parallel. Traditional parking lots primarily serve end-user vehicle owners. Under the E Park model, however, the service base expands to a coexistence of To B, To C, and To Robot - serving autonomous driving operators, end users, and robot devices themselves, thereby forming a new infrastructure ecosystem. At the same time, parking lots designed for unmanned systems can enable 24-hour automatic docking and a fully unmanned closed loop throughout the process through dedicated lanes, space-efficient design, energy-replenishment facilities, and data interfaces, thereby improving space utilization and overall operational efficiency.To turn this judgment into a replicable path in the real world, the key lies in validation and implementation in real scenarios. Shoucheng Holdings has chosen to begin with high-traffic, high-density transport hubs and core urban scenarios, promoting deep integration between robotic capabilities and parking assets. One landmark case is the introduction of the Hobbs W1 intelligent robot from Noetix Robotics at the Terminal 3 parking building of Beijing Capital International Airport, where technology was used to enhance both asset operating efficiency and passenger experience. Another example is Shoucheng Holdings' collaboration with its portfolio company Wisson Robotics to build the country's first automatic charging robot pop-up experience station in the underground parking lot at Chengdu IFS ICD, driving the parking lot's evolution from a single parking space into an intelligent operating scenario integrating parking and charging, and further validating the deep embedding of robotic technology into urban infrastructure.From a broader macro perspective, the reason Shoucheng Holdings has been able to advance this path lies in its ownership of an asset base capable of accommodating new demand. As Robotaxis, Robovans, and embodied intelligent robots accelerate into urban scenarios, cities will require a large number of distributed nodes to undertake energy replenishment, dispatching, and maintenance functions. Compared with building new facilities from scratch, parking lots naturally possess advantages such as wide geographic distribution, well-developed spatial conditions, easy access to power supply, and clearly defined asset characteristics. They have therefore become the most practical and efficient carriers for this new demand.Against this backdrop, Shoucheng Holdings' advantage in network-based deployment is being rapidly converted into real capability. The Company manages more than 100 parking lot projects nationwide, with a total area of several million square meters, covering core economic regions and providing a foundation for standardized retrofitting and large-scale replication. This means that its previously scattered static parking resources are now poised to be restructured into a multi-city, multi-node robot operating infrastructure network. At the same time, improvements at the operational level are also supporting this transition. In 2025, the Company's parking space turnover rate increased by 7.1%, its full-occupancy rate reached 55%, and innovative business revenue accounted for 20% of total revenue, demonstrating that through the application of AI technologies, refined operations, and expanding scenario applications, it is driving parking lots' transformation from traditional legacy assets into platform-based, growth-oriented assets.Accordingly, for Shoucheng Holdings, the proposition that "parking lots will become the largest robot operating bases in the future" is no longer merely a forward-looking judgment. It is a practical path that is being continually validated and is expected to achieve replication at scale. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut
CALB (3931.HK) Announces 2025 Results with Record Revenue of RMB 44,400.07 Million, Up 60% YoY ACN Newswire

CALB (3931.HK) Announces 2025 Results with Record Revenue of RMB 44,400.07 Million, Up 60% YoY

HONG KONG, Mar 28, 2026 - (ACN Newswire) - On March 27, CALB Group Co., Ltd. ("CALB" or "the Company," stock code: 3931.HK) announced its audited annual results for the year ended 31 December 2025 (the "Reporting Period"). During the Reporting Period, the Company’s total revenue for the year was RMB 44,400.07 million, representing a year-on-year increase of 60%; profit for the year was RMB 2,095.22 million, a year-on-year surge of over 140%, demonstrating a leap in profitability and continued momentum for high-quality development.In core business sectors, the Company’s market share for both power batteries and energy storage cells climbed significantly. In October 2025, CALB’s power battery installations reached a historic milestone, ranking among the global top three for the first time on a monthly basis. In early 2026, the Company stood out in the battery industry again with a huge growth of 630% YoY in the commercial EV sector.Deepening Global Market Presence with Dual Breakthroughs in Premium Market Positioning and Large-Scale ProductionIn 2025, as the global new energy industry flourished, shipments of power batteries and energy storage cells soared, with overseas markets becoming the core growth engine. Backed by all-scenario product capabilities, CALB accelerated its strategic layout toward both premium positioning and large-scale development.The Company’s market share in the passenger vehicle sector reached a new high. Its 5C super-charged battery, which has reached a monthly delivery sale of 20,000+ sets, exclusively supports popular models such as XPeng’s new P7 long-range version, supporting Xpeng further enhance its market competitiveness with a record-breaking driving mileage of 3,961km within 24h. Furthermore, CALB successfully entered the supply chains of international OEMs such as Toyota, Volkswagen, and Hyundai. Simultaneously, the Company deepened strategic partnerships with HUAWEI and Xiaomi, laying the groundwork for mass-scale delivery in 2026.The commercial vehicle segment also saw explosive growth, with shipments achieving a multiple-fold increase in 2025. With over 468 new vehicle models announced, the Company achieved full-scenario coverage and showed strong momentum as commercial battery shipments surged 630% YoY in early 2026. Overseas, the Company secured major rail transit and bus projects in Europe and won multiple international client awards.In the energy storage market, CALB achieved dual breakthroughs. Internationally, the Company entered the top-tier supplier lists in South Africa, Latin America, the U.S., and Israel. The next-generation “ZHIJIU” 600Ah+ cell secured mass production nominations. Domestically, partnerships with giants like SPIC (State Power Investment Corporation Limited) and CTG (China Three Gorges Corporation) were strengthened, further advancing the all-category energy layout in energy storage.Furthermore, the Company has established a forward-looking presence in emerging new energy sectors such as ship, low-altitude economy, and robotics, which represents a core highlight for the capital markets. In the shipping sector, several benchmark projects have already been implemented with large-scale deliveries, providing solid support for stable earnings growth. In the low-altitude sector, powered by core solid-state battery technologies, the Company has successfully commenced mass production of batteries for flying cars and secured exclusive nominations for major eVTOL models, perfectly aligning with the development trend of a trillion-dollar market. In the robotics sector, the Company has completed its product layout based on breakthroughs in all-solid-state battery technology. With batch deliveries set to begin, the Company is preemptively securing its position in the core energy track for humanoid robots, opening up significant growth opportunities for its future performance.Continuous Technology Leadership and All-Scenario Product Matrix AdvancementIn 2025, CALB achieved key breakthroughs in high-performance batteries, solid-state batteries, and advanced manufacturing. Product series such as “UP,” “ZHIYUAN,” “ZHIJIU,” and “Boundless” continue to define industry trends.Specifically, CALB is leading the way in super-charged and high-power battery technologies. The Company’s 5C super-charged batteries have reached large-scale commercialization, while the 10C super-charged batteries completed design and development in 2025. The 20C high-power batteries developed for HEV/PHEV models have been delivered for mass production to Geely and Dongfeng. For the luxury supercar and racing segments, the Company has completed prototype testing of its 25C high-power batteries, which boast megawatt-level discharge capabilities. Additionally, the advanced R46 cells have reached mass production and are being supplied to top-tier eVTOL customers, securing the No.1 market share in the sector.Technological upgrades were also synchronized across energy storage and commercial battery sectors. The “ZHIYUAN” series achieved 2C super-charged for heavy-duty trucks and a long lifespan of 10 years or 2 million kilometers, while light commercial EV batteries can support an upgraded mileage of over 350 kilometers. The “ZHIJIU” 588Ah/684Ah cells achieve zero degradation for 3 years and 15,000+ cycles, with an energy density of 450Wh/L.Significant breakthroughs were made in next-generation battery technologies, specifically in hybrid solid-liquid and solid-state batteries. The 400Wh/kg hybrid solid-liquid battery took the lead in powering new energy commercial vehicles with batch installations. The 450Wh/kg “Boundless” solid-state battery completed its original system prototype verification with industry-leading performance. Meanwhile, the commercialization process in emerging sectors such as low-altitude economy and robotics is accelerating, which is expected to help the Company further expand its global market share. In addition, the Company will continue to be driven by the dual engines of “technological innovation and management innovation,” forging systematic competitiveness for the future by pursuing excellence in both performance and cost management.“AI + Energy” Strategy: Empowering Industrial UpgradingBuilding on technological breakthroughs and guided by the “AI + Energy” strategy, CALB is driven by technological innovation and guided by the “AI + Energy” strategy, adhering to the deep integration of technological innovation and industrial innovation. Propelled by a future-oriented R&D layout, the Company has established a positive feedback loop of “new technology and product development – multi-market application – scaled delivery – refined operations – technological iteration and upgrade”—fully aligning with the current industrial trend of convergence between AI and new energy.Currently, CALB has established global industrial clusters across China, Europe, and ASEAN, providing a solid foundation for its global business expansion and long-term high-quality development.As the global energy transition accelerates, global demands are poised for sustained and rapid growth, with emerging application scenarios continuously surfacing. It is anticipated that the Company’s market share and profitability will enter a phase of accelerated expansion, further bolstering its global competitiveness and industry influence.About CALBCALB is a new energy enterprise specializing in the research, production, sales, and market application development of lithium batteries, battery management systems, and related integrated products and lithium battery materials. As Battery Expert, we aim to build a comprehensive energy operation system, to provide complete product solutions and full life-cycle management for the new energy application market, represented by power and energy storage.Currently, CALB has completed an all-round layout in domestic by setting up industrial bases in Changzhou, Xiamen, Wuhan, Chengdu, Hefei, Jiangmen and Meishan. Meanwhile, CALB has set up bases in Europe and ASEAN, vigorously expanding the layout all over the world to become a global leading enterprise with large-scale intelligent manufacturing capabilities. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut

Ausnutria 2025 Annual Results: Revenue Powered by International Business and Family Nutrition, Lean Management Underpins Operational Resilience

HONG KONG, Mar 28, 2026 - (ACN Newswire) - On 27 March, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK, hereinafter referred to as "Ausnutria" or the "Company") officially released its 2025 annual results announcement. According to the announcement, Ausnutria achieved revenue of approximately RMB7.488 billion in 2025, representing a year-on-year increase of 1.2%. The Company recorded EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of approximately RMB518 million. Excluding the impact of one-off non-recurring items, core EBITDA reached approximately RMB616 million, demonstrating the Company's steady progress in navigating industry cycles. In 2025, driven by the dual engines of Family Nutrition and International Business, Ausnutria achieved resilient revenue growth while making significant breakthroughs in product category mix and regional market expansion. Notably, the international business of Kabrita has approached the RMB1 billion mark, with a compound annual growth rate exceeding 50% for three consecutive years, as its new global business ecosystem continues to take shape at an accelerated pace.Over the past year, the global economy has been marked by complexity and volatility, with heightened uncertainties arising from geopolitical tensions, inflation and exchange rate fluctuations. Compounded by intensifying competition amid a contracting domestic infant milk formula (IMF) market, the industry has faced multiple severe challenges. Against this backdrop, Ausnutria has maintained its strategic resolve, deepening its core strengths. The Company's international business has continued to unleash its growth momentum, while the Family Nutrition business has flourished across multiple fronts. Market share in core milk powder categories has steadily increased, and the level of refined management has improved significantly. Through these multi-dimensional efforts to enhance operational resilience, Ausnutria has laid a solid foundation for its long-term development.Kabrita International Business Approaches RMB1 Billion Mark with CAGR Exceeding 50% for Three Consecutive YearsIn 2025, Ausnutria further accelerated its internationalization efforts, continuously strengthening its comprehensive capabilities in global supply chain deployment, localised operations and digital collaboration, driving continued explosive growth in its overseas business. During the reporting period, revenue from the international business of Ausnutria's goat milk formula brand Kabrita recorded a year-on-year increase of 50.7% to approximately RMB974 million, making it the first infant goat milk formula brand from a Chinese dairy company to approach RMB1 billion in overseas sales. With a compound annual growth rate exceeding 50% for three consecutive years, the growing contribution of overseas markets has become increasingly prominent.Revenue from the Middle East market recorded a year-on-year increase of 65.5%, accounting for 45.7% of total overseas revenue and maintaining its position as Ausnutria's largest overseas sales market. Growth in this region was primarily driven by strong performance across established markets including Saudi Arabia, the UAE, Qatar and Kuwait, where the Company strengthened its promotion through medical and healthcare professional channels, continuously enhancing the medical endorsement of its goat milk formula products in these markets. Saudi Arabia delivered a particularly outstanding performance, leveraging deep collaborations with local maternity, infant care and medical institutions to effectively boost consumer acceptance and market penetration. Notably, Kabrita was awarded the "Fastest Growing Brand" accolade by Nahdi, the largest pharmacy retailer in the country. The newly entered Oman market in 2025 also exceeded expectations, injecting fresh momentum into the Company's growth.Revenue from the Commonwealth of Independent States (CIS) market recorded a year-on-year increase of 40.1%, accounting for 23.9% of total overseas revenue. As one of the Company's earliest overseas markets, the CIS market has achieved full product category coverage for Kabrita, encompassing infant formula, cereals, fruit purees, biscuits and more, comprehensively meeting the diverse consumer needs in the region. Through its "360° Omni-channel Marketing" strategy and "DTC Loyalty Program", the Company has engaged target consumers in a distinctive manner, building high value-added brand recognition and continuously consolidating and strengthening its core competitiveness in this market.Revenue from the North American market recorded a year-on-year increase of 39.5%, accounting for 22.2% of total overseas revenue. In 2025, Kabrita successfully entered Walmart, the largest retailer in the United States, and has now expanded into 780 stores, progressively developing both online and offline channels to reach a broader consumer base. In the newly entered Canadian market, the Company has been deepening its presence through the core Walmart channel while gradually building momentum on Amazon.In addition, the Company achieved 100% year-on-year growth in the Southeast Asian market by strengthening product differentiation through formula upgrades, with a particular focus on advancing digital community engagement and deepening collaboration with e-commerce channels and local platforms.Family Nutrition Achieves Steady Growth, Building Multi-dimensional Foundations for Future SuccessAs the Company's continuously nurtured "second growth curve" business, Ausnutria's nutrition products business achieved steady growth in 2025, with revenue recording a year-on-year increase of 5.2%. According to the announcement, this revenue growth was primarily attributable to continuous innovation in star probiotic strains and products, precise execution of channel strategies, and the sustained release of brand equity.Research-driven brand development. Ausnutria entered into a six-year strategic partnership with Jiangnan University, establishing the Joint Innovation Centre for Microecology and Functional Dairy as well as the Collaborative Innovation Centre for Probiotics, embarking on a new chapter of full-chain innovation collaboration. In the B2B segment, the Company achieved several key breakthroughs in probiotic strains: Bifidobacterium longum subsp. infantis YLGB-1496 was approved by the National Health Commission (NHC) for inclusion in the list of edible bacterial strains for infants and young children. With this approval, Ausnutria now possesses two nationally approved infant probiotic strains, earning its distinction as the "double champion" in China's infant probiotics field. Additionally, the independently developed Bifidobacterium animalis subsp. lactis CP-9 obtained the U.S. FDA GRAS (Generally Recognized as Safe) certification, marking Ausnutria's achievement of world-leading standards in research innovation and quality control. The continuous breakthroughs in strain technology provide strong and enduring core momentum for brand development. In the B2C segment in 2025, NC Stomach Care Powder and NC Nasal Comfort Probiotics maintained top rankings in category search popularity on Xiaohongshu. As certified by Euromonitor International, NC was awarded the title of "No.1 in National Sales of Australian Brand Nasal Sensitivity Probiotics".Innovation in response to emerging consumer demands. Bio(R) (Baoyichang(R)) Active Lactic Acid Bacteria Powder introduced a mini space capsule design, setting new aesthetic standards for probiotic products. Yili Changshi Probiotics, formulated with the patented BL-99 strain, achieved a top position on e-commerce bestseller lists. Diversified dosage form solutions, including instant-dissolve powder and micro-effervescent tablets, have effectively enhanced the product competitiveness of business partners. Throughout the year, NC launched 17 new products including G13 Growth Capsules and Sleep Well Probiotics, building a precision nutrition matrix covering gastrointestinal health, nasal sensitivity, sleep, growth, eye and brain health, liver and kidney health, and women's health.Channel upgrades fueling business development. The Company continued to deepen its presence in pharmaceutical channels, achieving simultaneous growth in both scale and pace of expansion. Collaboration with leading platforms was further strengthened, driving rapid growth in private domain e-commerce. The application of star probiotic strains was reinforced, enabling continued expansion of brand clientele. The Company also made breakthroughs in overseas market reach by expanding into European and North American markets. NC achieved steady growth on mainstream e-commerce platforms such as Tmall and JD.com, with the Stomach Care and Nasal Comfort product lines becoming leading brands in the cross-border health supplement category through channels such as Sam's Club and China Duty Free (CDF). The Company partnered with XKA and Fengxiangjia to develop its private domain presence, building an incremental online growth matrix. Offline, the Company consolidated its core client base, expanded into potential customer segments, and achieved initial results from pharmaceutical channel pilot programmes, laying a solid foundation for diversified business development.Domestic Milk Powder Business Steadily Increases Market Share, Solidifying Core FundamentalsChina's infant milk formula (IMF) industry is currently undergoing a period of deep structural adjustment, facing multiple pressures including overall market contraction, intensifying competition, and channel transformation, while birth rate fundamentals and channel structure remain under sustained pressure. During the reporting period, Ausnutria solidified its core fundamentals amid cyclical industry challenges, achieving steady growth in market share for its self-owned milk powder brands and recording overall revenue of approximately RMB5.321 billion.According to NielsenIQ and Syntun data, Kabrita's market share in China's all-channel Goat Milk formula market increased by 2.6 percentage points to 30.2% in 2025. NielsenIQ data further shows that Kabrita has maintained a market share of over 60% in China's imported infant and child goat milk formula market for eight consecutive years (2018–2025). Confirmed by Frost & Sullivan research, Kabrita continues to hold the undisputed position of "No.1 in Global Goat Milk Formula by Both Sales Volume and Sales Value", underscoring its unassailable market leadership.NielsenIQ data also indicates that the Company's cow milk formula business has stabilised its market share, marking the full conclusion of the transitional impact arising from earlier internal integration and channel restructuring. As of the date of this announcement, Ausnutria's Hyproca brand has been awarded dual certifications by iiMedia Research, namely "No.1 in National Sales of Comprehensive Nutrition Infant Formula in 2025" and "Pioneer of Comprehensive Nutrition Infant Formula in China", marking the third consecutive year that Hyproca has topped the comprehensive nutrition formula sales rankings.In 2025, the Company successfully completed the registration of 24 products across 8 series under the New National Standard 2.0 and launched 6 infant formula products across 2 series as well as 25 modulated milk powder products, offering consumers a wider range of functionalised and differentiated product choices. Kabrita was awarded the First Prize for Technological Advancement at the Science and Technology Awards for its research and development project titled "Research and Development of an Infant Formula that Supports Immune Regulation and Alleviates Immune Stress". Meanwhile, Hyproca 1897 was recognized as a "100% Quality Product", with the Company's product strength receiving authoritative endorsement.Lean Management Enhances Quality and Efficiency, Organizational Vitality Continues to FlourishIn 2025, Ausnutria continued to solidify the foundation for long-term development and achieve simultaneous improvements in organizational efficiency and development quality through a series of initiatives, including fully leveraging the momentum of its global supply chain, strengthening internal management effectiveness, establishing the cultural foundation for global collaboration, advancing the construction of its digital intelligence system, and enhancing its sustainable development governance capabilities.Global supply chain momentum unlocks new value growth opportunities. Following Ausnutria's acquisition of Amalthea Group, a Dutch goat cheese company, the Company achieved self-sufficiency in goat whey, a core ingredient for goat milk formula, while also adding cheese to its product portfolio. In 2025, the Company's Goat Cheese business recorded revenue of RMB1.006 billion, further deepening the moat of its internationalization strategy. Concurrently, the Company launched four major goat-based ingredients: goat cheese protein hydrolysate, hydrolyzed goat whey protein powder, goat lactoferrin, and goat colostrum powder. Several of these core goat milk ingredients achieved breakthroughs in commercially viable global applications from scratch, opening up new avenues for value creation for the Company.Internal management effectiveness strengthened to systematically drive sound operations. In 2025, the Company's inventory impairment provisions decreased by 0.9 percentage points year-on-year. Overall asset turnover ratio continued to improve, with inventory turnover days declining by 16 days. The Company continued to advance refined cost management, achieving a notable optimization in its expense ratio, which decreased by 1.4 percentage points year-on-year, with the selling and marketing expense ratio declining by 2.4 percentage points year-on-year.Global systematization of business philosophy to strengthen global strategic synergy. To better align with the pace of business development and reinforce Ausnutria's "one global chessboard" strategic approach, the Company officially released the "Ausnutria Business Philosophy (Overseas Edition)". Co-created through multiple rounds of in-depth discussions among over 60 core managers from Ausnutria's global operations, this business philosophy systematically establishes the core values and management principles for Ausnutria's overseas business. It serves as a tailor-made cultural compass and behavioral benchmark for overseas teams, laying a solid ideological foundation for future business development.Full-chain digital intelligence upgrade, empowering both business and management. The Company has introduced digital intelligence across all stages, from demand research and process design to implementation and execution, enabling traceable decision-making, monitorable processes and quantifiable results. Through the establishment of a data middle platform, intelligent analytical models and other tools, data has become the core enabler for optimising management and supporting business operations, fundamentally safeguarding the sustained and healthy development of the business.Upholding sustainable development principles and actively fulfilling corporate social responsibility. The Company has always adhered to a long-term vision for sustainable development, actively responding to the United Nations Sustainable Development Goals. Centred on three strategic pillars "Better Life, Better Nutrition, Better Environment” the Company has embedded sustainability principles into its operational management framework and across all stages of the value chain. In 2025, Ausnutria organized the "Hyproca Gesang Flower Charity Campaign" for the ninth consecutive year and launched the "Kabrita Care · Worry-free Pregnancy" maternal mental health charity initiative, among other activities. The Company has continued to contribute its corporate strengths in areas such as rural revitalization, education support, national nutrition enhancement and natural disaster relief.In 2025, with the support of consumers, shareholders and all sectors of society worldwide, together with the dedicated efforts of all employees, the Company successfully navigated the multiple challenges arising from economic and industry cyclical adjustments. Looking ahead to 2026, the internal and external environment remains complex and challenging. Ausnutria will continue to put consumers at the center, stay anchored to its operational objectives, accelerate systematic organizational development, drive growth through innovation, enhance efficiency through management excellence, and deliver superior products and performance to reward the trust of all stakeholders, in pursuit of long-term sustainable and high-quality development. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut
Gench Education Announces 2025 Annual Results ACN Newswire

Gench Education Announces 2025 Annual Results

Financial HighlightsFor the year ended 31 December (RMB’000)20252024Change%Revenue1,004,586969,854+3.6%Gross profit544,651539,894+0.9%Profit before tax318,601298,331+6.8%Profit for the year242,548223,618+8.5% HONG KONG, Mar 28, 2026 - (ACN Newswire) - 27 March 2026, Shanghai Gench Education Group Limited (“Gench Education” or the “Company”, together with its subsidiaries, the “Group”, Stock Code:1525.HK) -- the leading higher vocational education group in East China and the largest higher vocational education group in Shanghai, delightedly announced its consolidated financial results for the year ended 31 December 2025 (the “Reporting Period”).During the Reporting Period, the Group recorded revenue of approximately RMB1,005 million, representing an increase of 3.6% year-on-year (“YoY”). Gross profit was RMB545 million, up 0.9% YoY; Profit for the year of approximately RMB243 million, a YoY rise of 8.5%. Basic earnings per share attributable to ordinary equity holders of the parent were RMB 0.61, up 7.0% year-on-year. The growth was mainly driven by the increase in student enrolment, optimization of tuition rates and expansion of education-related services. The Group proposes to declare a final dividend of HKD$0.04 per share for 2025. Together with the interim dividend of HK$0.10 per share for the six months ended 30 June 2025, the total dividend for 2025 will be HK$0.14 per share, maintaining a stable dividend policy to reward shareholders.Policy Dividends Deliver with Precision, Lingang Advantages Unleash Development PotentialIn 2025, the national “Outline of the Plan for the Construction of a Stronger Education State (2024-2035)” and the industry-education integration policies of Lingang New Area jointly created a favorable policy environment for the Group’s development. As the only private university in Lingang New Area, Shanghai Jian Qiao University (the “University”) has closely aligned with the regional industrial layout and seized the opportunities brought by the clustering of strategic emerging industries including integrated circuits, life health and high-end equipment manufacturing, achieving precise matching between educational resources and industrial demands. “The Shanghai ‘Lingang Science Innovation Town’ Construction Plan” clearly proposes to leverage the science and technology innovation resources of universities. Taking this opportunity, the University has become a core participant in industry-education integration in Lingang. It has not only obtained special policy and resource support, but also transformed geographical advantages into unique competitiveness through targeted talent training and joint technological research and development. As of 31 August 2025, 77.5% of the University’s 2025 graduates were employed in the Yangtze River Delta region and 59.2% in Shanghai, deeply integrating into the regional development ecosystem.Digital-Intelligent Transformation Yields Remarkable Achievements, Teaching Quality Scales New HeightsDriven by technological innovation in education and teaching upgrading, the University achieved a number of landmark results in curriculum digitalization and smart campus construction in 2025. In terms of curriculum innovation, the University has built a multi-dimensional curriculum system covering “AI + courses”, “industry-education integration courses” and other types. A total of its 26 courses were approved as Shanghai higher education municipal level key courses, among which “AI + courses” accounted for 50%. “Fundamentals of Gemstone Geology and Crystallography” offered by College of Jewelry was successfully selected as a national “Online/Offline Hybrid First-Class Course”, achieving a breakthrough in the construction of national first-class courses. The University has developed a total of 1,253 online open courses, continuously expanding the scale of digital teaching resources. In smart campus construction, the University continues to deepen the upgrading and modification of teaching and scientific research instruments and equipment as well as teaching laboratories, independently developed smart platforms such as the Cloud Teaching Centre and Cloud Examination Centre, and embedded AI, 5G, VR (virtual reality) and other technologies into the teaching reform process. In addition, the University has built the DeepSeek Gench Education Applied Big Model and launched three smart systems for teaching, management and services, achieving refined campus management and personalized services.In terms of faculty development, as of 30 September 2025, among the full-time teachers, the master degree or higher accounted for 86.4%, the doctoral degree accounted for 28.8%, the senior title accounted for 38.6%, and the double-position accounted for 47.8%. The University has promoted the development of teaching staff towards high quality and professionalism through faculty mentoring, specialized training, and encouraging teachers to take part in various teaching competitions. In 2025, the teaching team won numerous awards in national and regional teaching competitions, earning industry-wide recognition for their capabilities. Meanwhile, the University’s disciplinary strength maintained a leading position. According to “2025 First-class Majors Ranking (Application-oriented) in China” by CUAA.net, its 29 majors ranked among top 10 in China, among which 13 majors ranked first nationwide. The employment rate of year 2025 graduates reached 99.4%, the college-entrance rate reached 5.8%, and the rate of studying abroad reached 5.3%, particular with 94 graduates admitted to top 50 universities/colleges and 123 graduates admitted to top 100 universities/colleges in QS World University Rankings. These results demonstrate that the quality of talent training has been widely recognized.Industry-Education Integration Accelerates, Building a Collaborative Ecosystem for School-Enterprise SynergyIn 2025, the University accelerated the construction of an industry-education integrated university and established a “three-in-one” operation model of “Secondary Colleges + Industrial Colleges + Entity Companies”, forming a multi-dimensional collaborative education ecosystem. The University has made comprehensive progress in its industry college development. The University has established the Medical Engineering Industry College and the Live Streaming Economy Industry College, and meanwhile actively drove the construction of the Big Data Industry College, the IC Industry College and the Intelligent Manufacturing Industry College. The “Digital Smart Manufacturing” and “Integrated Circuit” industrial colleges had been awarded as Shanghai municipal key modern industrial colleges. Major platforms were successively launched in a string. The national level platform “IC Packaging and Testing Industry-Talent Collaboration and Innovation Centre” & Lingang Industry-Education Integrated Practice Base was created. Lingang Jewelry Art Centre was opened, integrating public exhibition, entrepreneurship incubation, science generalization & education, appraisal & design, fashion & consumption among other functions. During the year, the University conducted 8 key industry-education integrated projects, and added 20 new industry-education integrated courses with teaching materials, further deepening school-enterprise collaboration. School facilities were continuously improved. The phase four campus facilities were fully operational in March 2025, with a total gross floor area of approximately 86,400 square meters, including a teaching and training building, talent apartments and a multi-functional research and development center, providing a solid foundation for school-enterprise joint research and student practical training.International Cooperation Reaches a New Level, Lifelong Education System Steadily ImprovesThe Group has been deeply engaged in private higher education for 25 years, with its brand reputation and industry position steadily rising. According to CUAA.net, the University has ranked third among Category I private universities in China for five consecutive years and first among private universities in the Yangtze River Delta for seven consecutive years. It has passed the reexamination of “National Model Unit of Civilization” three times and won many honors including the first batch of “Lei Feng Spirit University Demonstration Education Bases” and “Contribution Award for Promoting Lei Feng Spirit in the New Era”. Its quality of education has received wide recognition from society. International business continued to expand. In 2025, the University contracted with 11 overseas famous universities/colleges in Germany, United Kingdom, New Zealand, Thailand and other countries, received cumulatively 43 batches of delegations of overseas famous institutions, and published more than 30 foreign/overseas exchange projects (like UN international NGO training, overseas famous university/college visit, overseas famous enterprise internship), continuously broadening channels for teachers and students to exchange overseas.The lifelong education system has been continuously improved to meet the diverse learning demands of all communities. As of 31 December 2025, the number of adult students of the continuing education programs reached 3,760, and more than 400 types of vocational skill certificate training were provided. In addition, as a continuing education base for high end equipment industry workers and a continuing education base for fashion consumption and logistics industry workers, the University applies for Shanghai “dual system” workers continuing education higher education pilot base (incubation) project, and the project is initiated.Looking to the future, Mr. Zhao Donghui, Chairman of the Board and Executive Director of Gench Education, stated: “The steady growth of the Group’s performance in 2025 confirms the effectiveness of the high-quality development strategy. Going forward, we will continue to take digital and intelligent transformation as the driver, deepen the industry-education integration collaborative education model, seize the historic opportunity of building Lingang New Area into a world-class science innovation town, further optimise the professional layout, enhance the teaching capacity and improve the campus ecosystem. We are committed to preliminarily completing the transformation of an industry-education integrated university by 2030 and fully accomplishing it by 2035, building a world-class private university with international influence, and sharing the dividends of high-quality development of vocational education with all shareholders.”About Shanghai Gench Education Group LimitedGench Education (Stock Code: 1525.HK) is a higher vocational education group which provides undergraduate education and junior college education, focusing on high-quality schooling for the provision of excellent education for students. The Group operates Shanghai Jian Qiao University, being the domestic leading private university, at Lingang New Area of China (Shanghai) Pilot Free Trade Zone. As measured by the number of full-time students enrolled in the 2025/26 school year, the University is the largest private university in Shanghai and is also a leading private university in the entire Yangtze River Delta. According to CUAA.net, the University ranked third among all category I private universities in China for five consecutive years and first among private universities in the Yangtze River Delta for seven consecutive years. Over 25 years of operation, the schooling quality of the University ranked in the forefront of peer universities, which has accumulated a solid brand reputation. Since 2004, the University has been consecutively awarded “Shanghai Civilized Unit” over 18 years. The University has won numerous honorary titles such as “National Model Unit of Civilization”, “Shanghai Garden Unit”, “Shanghai Safe and Civilized Campus”, etc. The University has also been granted reputable title of “Lei Feng Spirit College Demonstration Education Base” among the first batch of universities in the PRC in April 2024, and was awarded the “Contribution Award for Promoting Lei Feng Spirit in the New Era” in September 2024.This press release is issued by Porda Havas International Finance Communications Group on behalf of Shanghai Gench Education Group Limited. For further information, please contact:Porda Havas International Finance Communications GroupE-mail: gench.hk@pordahavas.com Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut
Vantage Goldfields Corrects Misleading Announcement by Lions Bay Capital Inc. (LBI) ACN Newswire

Vantage Goldfields Corrects Misleading Announcement by Lions Bay Capital Inc. (LBI)

SYDNEY, AU, Mar 28, 2026 - (ACN Newswire) - Vantage Goldfields Limited (Vantage Goldfields) owns Vantage Goldfields Pty Ltd (VGL), Barbrook Mines Pty Ltd (Barbrook) and Makonjwaan Imperial Mining Company (Pty) Ltd (MIMCO) (collectively the Vantage Companies), which own the Lily and Barbrook mines in South Africa. The Vantage Companies are currently in business rescue in South Africa, which is the legal process that assists financially distressed companies restructure, or otherwise avoid liquidation.An announcement was made on 26 March 2026 by TSX-V listed Lions Bay Capital Inc. (Lions Bay), which the Vantage Companies believe is misleading to investors and fails to disclose material information (the Announcement). That Announcement referred to Lions Bay receiving approval from a business rescue practitioner (BRP) of the Vantage Companies and calling a meeting of creditors to approve business rescue plans for the Vantage Companies.The Announcement is misleading and fails to disclose relevant material information regarding the Vantage Companies and Lions Bay proposal, including:While the Announcement referred to a Business Rescue Practitioner (BRP) (being Mr Devereux) approving the Lions Bay proposal, it failed to disclose that the Vantage Companies have two appointed BRPs and the second BRP has not approved the Lions Bay's proposal. Both BRPs have to approve a proposal in order for it to be presented to creditors. The second BRP was appointed by the Boards of the Vantage Companies, and his appointment was confirmed by the Companies and Intellectual Property Commission (CIPC), the corporate regulator in South Africa.The second BRP was appointed to ensure that all viable proposals for the rescue of the Vantage Companies are properly considered and that a business rescue is then properly and lawfully implemented for the benefit of all stakeholders, including creditors, former employees and the local community, as soon as possible.Vantage Goldfields as the owner of the Vantage Companies and Lily and Barbrook mines, has received a number of viable proposals for the rescue of the Vantage Companies and the reopening of those mines, which should be properly considered by the BRPs. These proposals should result in a better outcome for creditors and other stakeholders of the Vantage Companies than the Lions Bay proposal.Mr. Devereux acted unilaterally and unlawfully in purporting to approve an offer from Lions Bay and convene a meeting of creditors of the Vantage Companies. Vantage Goldfields believes that Mr. Devereux misled such creditors by failing to disclose that Lions Bay does not have the necessary US$40 million in funds to be able to complete its proposal.The Announcement failed to disclose that for the Lions Bay proposal to be able to be implemented, an approval from a BRP is not legally sufficient to be able to implement that proposal, and that proposal would need to be approved by specified majorities of creditors of each of the Vantage Companies. Vantage Goldfields has been informed by the largest secured creditor of the Vantage Companies that it does not support and will not vote in favour of the Lions Bay proposal at the necessary meetings of creditors, on its current terms and given that Lions Bay does not have all the necessary funds to complete the proposal. That creditor also has not agreed to release its securities over the asset of the Vantage Companies.Therefore, the necessary approvals of creditors will not be obtained, and the Lions Bay proposal will not be able to be implemented as currently proposed.Vantage Goldfields intends to ensure that all viable proposals are properly considered for the business rescue of the Vantage Companies, and that the business rescue process is progressed and implemented properly in accordance with South African law. Vantage Goldfields remains fully committed to reopening the Lily and Barbrook mines for the benefit of all creditors, former employees, affected persons and other stakeholders of the Vantage Companies.Stephen TurnerChairman-Vantage Goldfieldsst@stephenturner.com.auThis press release contains forward-looking statements, including statements about our future operations, plans, objectives, expectations, estimates, forecasts, or projections. Forward-looking statements are inherently subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results, performance, or outcomes to differ materially from those expressed or implied.Under Australian law, statements about future matters must be based on reasonable grounds at the time they are made or they may be considered misleading. We believe the forward-looking statements in this release are based on reasonable grounds; however, events or circumstances may cause actual results to differ.These risks and uncertainties may include, among other things, changes in market conditions, economic factors, industry developments, operational challenges, regulatory changes, and other factors known or unknown to the company.Forward-looking statements speak only as of the date of this release, and except as required by law, the company undertakes no obligation to update or revise any forward-looking statements to reflect new information, future events, or changed circumstances.Source: Vantage Goldfields Limited Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut

Trio Industrial (1710) 2025 Recorded Revenue at approximately HK$775.3 million; Continues to implement Dual‑engine Strategy of Electronic Manufacturing Services and New Energy Businesses

EQS Newswire / 27/03/2026 / 23:12 UTC+8 【For Immediate release】 Trio Industrial Electronics Group Limited (Stock Code: 1710.HK) Announces 2025 Annual Results* * * Recorded Revenue at approximately HK$775.3 million Continues to implement Dual‑engine Strategy of Electronic Manufacturing Services and New Energy Businesses to Build a “Greater Asia New Energy Business Network” (Hong Kong – 27 March 2026) Trio Industrial Electronics Group Limited (“Trio Industrial” or the “Group”; stock code: 1710), a leading manufacturer and distributor of advanced industrial electronic components and products in Hong Kong, today announced the annual results of the Company and its subsidiaries (the “Group”) for the year ended 31 December 2025 (the “Year”). During the Year, the overall operating environment remained challenging. Europe and North America continued to be the Group’s major markets, where operating conditions were affected by relatively tight interest rate conditions, ongoing geopolitical tensions and the implementation of the revised tariff policy in the United States. In response, many customers adopted a more prudent procurement approach, focusing on inventory management and adjusting their purchasing strategies, which led to weaker demand during the Year. As a result, the Group’s revenue for the financial year 2025 decreased by approximately 23.1% year‑on‑year to approximately HK$775.3 million. Nevertheless, the Group maintained stringent cost control and optimised its staffing and labour structure, resulting in a decrease in overall administrative expenses compared with last year. Overall, the Group recorded a gross profit of approximately HK$139.6 million for the financial year 2025, representing a decrease of approximately 25.5% compared with the previous year, while gross profit margin decreased by 0.6 percentage points from 18.6% to 18.0%. The Group recorded a loss attributable to owners of the Company of approximately HK$35.4 million for the Year. The Group maintained a healthy financial position, with cash and cash equivalents (including restricted bank deposits) of approximately HK$140.5 million and a net cash position (cash and cash equivalents less borrowings). The current ratio was approximately 2.7 times, similar to that as at 30 June 2025 and 31 December 2024. To navigate the complex and evolving global market environment, Trio Industrial is accelerating the implementation of its joint design manufacturing strategy, deepening cooperation with key customers and enhancing value‑add and profit potential from the product design stage, while strengthening long‑term customer relationships. In line with this direction, the Group is actively recruiting professionals who possess both technical expertise and market insights to enhance its global sales and engineering teams, further expand market coverage and support future business growth. In terms of global manufacturing network, the Group’s Thailand production facility serves as a strategic export base for the United States of America and Southeast Asian markets, providing greater flexibility in addressing geopolitical developments and tariff barriers. The Group’s manufacturing facility in the United Kingdom commenced operation in the second quarter of 2025 to serve local customers in Europe and strengthen supply chain security. The Group is also establishing a new manufacturing facility in the United States of America, which is expected to commence operation in the second half of 2026. With a manufacturing network spanning the PRC, Thailand, the United Kingdom and the upcoming facility in the United States of America, the Group is able to offer global customers diversified regional supply assurance and flexibility in response to geopolitical changes and the reshaping of trade patterns. This network not only enhances supply chain resilience, but also underscores the Group’s competitive advantage of “global manufacturing, local services”. In the new energy sector, while optimising the operations of its electronic manufacturing services business, the Group has continued to expand its business from electric vehicle charging manufacturing and charging station operation to include energy storage and distributed energy applications, thereby building an integrated “charging–storage–energy services” business model and further consolidating its position along the new energy value chain. Leveraging the “Belt and Road” Initiative, the Group has established first‑mover platforms in Central Asia and Southeast Asia and is advancing distributed energy storage and e‑mobility projects with regional demonstration effects, injecting new momentum into its medium‑ to long‑term growth. In Kazakhstan, the Group has partnered with Sinooil (a subsidiary of China National Petroleum Corporation) to deploy electric vehicle charging infrastructure and digital advertising facilities at approximately 140 Sinooil petrol stations across the country, creating a scalable platform for the Group’s integrated energy and media business. The Group has established four EV charging stations in Kazakhstan, one of which adopts a “solar‑storage‑charging” configuration, integrating Deltrix EV charging infrastructure, energy storage systems, digital advertising kiosks and intelligent car‑wash facilities. While providing EV charging services, these sites also create a comprehensive ecosystem that combines energy services, digital advertising, automatic car‑wash facilities and convenience retail. This integrated advertising platform is also designed to support Chinese enterprises in expanding into Central Asia and to strengthen the Group’s presence in the regional outdoor media market. Building on this strategic platform in Central Asia, the Group is also expanding its new energy business in Southeast Asia, with the Philippines as the first market in the region. The Group is rolling out Deltrix‑branded electric motorcycles and battery‑swapping projects, offering an integrated “vehicle–battery–cabinet” solution for e‑mobility, which is a typical distributed energy storage application. At the same time, the Group is developing other distributed energy storage solutions for residential, commercial and industrial applications, further broadening its portfolio of new energy products and services in the region. Mr. Cecil Wong, the Chairman of Trio Industrial Electronics Group Limited said, “Despite the continued challenges in the global economic environment, we remain confident in the long‑term trends of industrial electrification, sustainable energy and intelligent development. The Group’s strength lies in combining its expertise in electronic manufacturing with new energy technologies, and in driving business development through a multi‑country manufacturing footprint and technology‑driven execution. Over the next three years, we will focus on business areas with sustainable growth potential, strong technology orientation and clear market demand to further enhance the Group’s earnings quality and cash flow performance.” “At the same time, we will promote deeper integration of artificial intelligence and the Internet of Things to build the ‘Group Intelligent Energy Brain’, using data to drive operational efficiency and transparency in energy management, and ultimately achieve the transformation from a manufacturing enterprise into an intelligent energy ecosystem platform. We believe that by continuously optimising operational efficiency and advancing the integrated development of ‘new energy + new media’, Trio Industrial will further strengthen its competitive advantages amid a rapidly changing market environment, open up high value‑added and sustainable growth opportunities and create long‑term value for shareholders.” - End - About Trio Industrial Electronics Group Limited (Stock Code: 1710.HK) Trio Group is a leading Hong Kong-based manufacturer and supplier of advanced industrial electronic components and products, with over 40 years of industry expertise. Specialising in power supply solutions, the group serves key sectors such as energy efficiency and medical electronics. As the first Hong Kong electronics supplier to achieve Industry 4.0 maturity certificate - industry 4.0 1i level. Trio Group integrates smart manufacturing and innovative technologies to deliver high-performance solutions, earning a strong reputation as a trusted partner for numerous globally recognised brands, primarily in Europe and North America. In response to the growing emphasis on ESG (Environmental, Social, and Governance) principles and the urgent demand for decarbonisation, Trio Group is strategically expanding into the renewable energy sector through its proprietary brand, Deltrix. The company is actively developing solutions in: EV charging infrastructure Solar energy storage systems Smart power management Charging network deployment With a focus on Central Asia and Southeast Asia, Trio Group is committed to advancing green technology innovation, positioning itself as a key player in the global energy transition while driving sustainable business growth. By leveraging its technical expertise and forward-looking strategies, the group continues to reinforce its role in shaping a low-carbon future. This press release is issued by DLK Advisory Limited on behalf of Trio Industrial Electronics Group Limited. For further information, please contact: DLK Advisory 金通策略 Email: pr@dlkadvisory.com Tel: +852 2857 7101 File: 1710_2025AR_press release_EN_20260327_FINAL 27/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Lebih lanjut
Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic ACN Newswire

Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic

HONG KONG, Mar 27, 2026 - (ACN Newswire) - In the Hong Kong stock market, the key to consistently winning investor trust lies not just in periodic earnings growth, but in the ability to stably transform operating results into shareholder returns. According to the latest 2025 annual results report disclosed by Shoucheng Holdings (0697.HK), the company proposes a dividend of 780 million HKD, corresponding to an average annual market value dividend yield of approximately 5.6%. Looking at the long term, since its strategic transformation in 2018, the company has continuously advanced business transformation and structural optimization, leading to steady improvements in profitability and cash flow quality. It has maintained stable dividends for many consecutive years, with a cumulative dividend scale of approximately 6 billion HKD over eight years, shifting the investment logic from "growth expectations" toward "balancing both growth and returns".It is noteworthy that this dividend does not rely on high leverage or short-term overdrafts; rather, it is a proactive return built on improved balance sheets, enhanced operating quality, and optimized cash flow. As of December 31, 2025, the company's bank balances and cash stood at 3.671 billion HKD, with total borrowings of 979 million HKD. The cash-to-interest-bearing debt coverage ratio is approximately 3.75 times, demonstrating strong dividend sustainability and a significant financial safety margin.Over the past eight years, Shoucheng Holdings has gradually formed a smart infrastructure asset service system centered on parking asset management, industrial space management, REITs investment, and equity investment, constructing a composite model of "operational efficiency + asset management + capital circulation". Mature businesses such as parking and industrial parks continue to provide steady cash flow, serving as the practical foundation for the company's dividends. Meanwhile, REITs investments, the robotics ecosystem, and emerging industry funds further open up space for profit realization and valuation enhancement.Among these, the robotics business is becoming a significant incremental driver of Shoucheng Holdings' long-term value. In recent years, the company has continuously refined its robotics layout around "investment + operations + ecosystem," systematically investing in several leading robotics enterprises. Through scenario integration, channel construction, and industrial services, it has pushed projects from technical verification to commercial implementation. As relevant companies accelerate financing, see valuation increases, or move toward IPOs, the robotics segment is expected to continuously strengthen the company's mid-to-long-term profit release and shareholder return capabilities.Furthermore, in the latest Chairman's Statement, Chairman Zhao Tianyang explicitly expressed "gratitude" to investors and continued to emphasize "creating long-term value for investors". This statement is not merely a declaration of attitude but sends a clear signal: Shoucheng Holdings is placing shareholder returns and long-termism in a more prominent position. For the market, the significance of eight years of continuous dividends has long transcended a simple profit distribution; it serves as a more certain anchor of confidence for long-term capital amidst complex economic cycles. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut

Uni-Bio Science Group Limited Announces 2025 Annual Results

EQS Newswire / 27/03/2026 / 21:31 UTC+8 Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents Dividends Distributed for Two Consecutive Years Embarks on Innovation-Driven Transformation to Become a Global Pioneer in Regenerative Medicine (27 March 2026 – Hong Kong) A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”). Key Accomplishments in 2025 During the Year, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include: During the Year, the Group delivered record-breaking financial results, with revenue recorded a 6.0% year-on-year (“YoY”) increase, reaching approximately HK$586.2 million. Profit for the year soared by 12.7% YoY to approximately HK$93.3 million, and net profit margin increased by 1.0 percentage points YoY to 15.9%, marking a historic high. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY or a CAGR of 18.55% from 2023 to 2025. The Group generated solid cash from operations in the Year, operating cash flow and free cash flow increased by 32.7% and 27.3% YoY, respectively. Cash ratio increased from 0.53 times at the end of 2024 to 1.63 times at the end of 2025. The cash conversion cycle improved from 124 days to 107 days, highlighting greater operating efficiency. Backed by sustainable earnings and a healthy cash flow, the board of directors (“Board”) has declared a dividend payment for 2025 of HK$0.313 cents per share. Since its official launch in March 2024, Bogutai® has sustained strong growth momentum, driven by a solid commercialization strategy and successful academic engagement. In 2025, Bogutai® demonstrated rapid market adoption in China, achieving a remarkable year-on-year revenue growth of 111.0%. In May 2025, the Group’s second ophthalmology product, 金因康® (Diquafosol Sodium Eye Drops), received marketing approval from the China National Medical Products Administration (“NMPA”), marking a significant milestone in expanding the Group’s ophthalmic portfolio following GeneSoft®. The Group is actively preparing its launch and marketing strategy. In addition to leveraging synergy with GeneSoft® and its established online and offline distribution network for rapid market penetration, 金因康® will specifically target the mid-to-high-end segment of dry eye patients outside the hospital setting, those who prioritize long-term efficacy and premium product quality. In June 2025, the Group officially launched the high-end series GeneQueens® of 肌顏態® and the medical device brand 金因敷®, marking two key milestones in its strategic expansion into the integrated“Drug, Medical Device, and Aesthetics”field. These product launches reflect the Group’s commitment to enhancing its skin health product matrix and addressing evolving consumer needs for efficacy-driven, medical-grade skincare in both functional skincare and post-aesthetic recovery. In July 2025, the marketing application of Isavuconazonium sulfate capsules were officially accepted by the NMPA. Isavuconazonium sulfate capsules are expected to be approved for launch as early as the fourth quarter of 2026, offering a safer, more effective, and high-quality treatment option for patients suffering from invasive fungal infections. In 2025, the Group established a strategic partnership with Wenzhou Medical University to explore a thermosensitive gel formulation combining EGF and bFGF, leveraging the university’s proven expertise in bFGF production. As a key growth factor in regenerative medicine, bFGF is highly effective in promoting granulation and angiogenesis. Towards the end of 2025, the Group repositioned its long-term strategy from “Stable Growth” to “Innovation-Driven,” signifying a bold transformation from an integrated pharmaceutical company into a global pioneer in regenerative medicine. The Group is advancing a transformative R&D strategy spanning four key areas: muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration. Annual Results For 2025, the Group recorded a revenue of approximately HK$586.2 million, representing an increase of 6.0% YoY. Revenue from Bogutai® increased from approximately HK$ $63.5 million to approximately HK$ 134.0 million, representing a significant increase of 111.0%. Revenue generated from GeneTime® was approximately HK$220.4 million, representing an increase of 10.9% YoY. GeneSoft® recorded a 7.9% YoY decrease in revenue from approximately HK$41.9 million to approximately HK$38.6 million due to intense market competition. Pinup® recorded a decrease of 29.4% in revenue from approximately HK$244.2 million to approximately HK$172.5 million for the Year. In 2025, the Group adopted a more disciplined and selective hospital-supply strategy under volume-based procurement (VBP) to safeguard margins, particularly in regions where policy adjustments intensified price competition. At the same time, the Group accelerated diversification into pharmacy networks beyond traditional hospital channels and optimized its supply chain to improve cost and profitability. In 2024, Boshutai® was successfully included in the VBP by the Henan Seventeen Provinces Alliance and the procurement validity period is set for two years. Hospitals in many provinces began procuring Boshutai® in 2025. Following the destocking and a low base in 2024, revenue from Boshutai® increased from approximately HK$10.2 million to approximately HK$15.5 million, representing a significant increase of 51.9%. 肌顏態® generated approximately HK$2.8 million in revenue in its early stage. The limited revenue scale reflected several factors, including a relatively small number of products approved and launched during the Year, and the fact that specialized marketing and distribution teams were still being built and optimized. Gross profit was approximately HK$487.6 million, representing an increase of 5.7% as compared with approximately HK$461.1 million in 2024, and gross profit margin increased by 0.2 percentage points YoY to 83.2%. The Group delivered another year of record-breaking profit, achieving approximately HK$93.3 million for the Year, representing an increase of 12.7% YoY. Net profit margin increased by 1.0 percentage points YoY to 15.9%. These results demonstrate the Group’s success in converting product innovation into market value through strong commercialization execution and financial discipline. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY. Prospects Regenerative medicine has emerged as a rapidly developing field, focused on repairing, replacing, or regenerating damaged tissues or organs using cells, tissues, or genetic material. The sector has the potential to treat and address the underlying causes of chronic and advanced diseases. The global regenerative medicine market was approximately USD51.7 billion in 2025. It is projected to grow from USD63.0 billion in 2026 to USD555.6 billion by 2034, representing a compound annual growth rate (CAGR) of 31.3%. The increasing prevalence of chronic and hereditary diseases, together with rising healthcare expenditure in both developed and emerging markets, is expected to support continued growth in the regenerative medicine industry. Mr. Kingsley Leung, Chairman of Uni-Bio Science, commented, “In 2025, we are proud to have delivered another year of record profitability, marking a significant milestone in our growth journey. During the year, we entered a new phase of strategic development. In anticipation of an increasingly favorable market environment, we advanced our strategic transition from ‘stable growth’ to ‘innovation-driven’ development, with a clear focus on four diversified therapeutic areas: musculoskeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration. With multiple products progressing through our pipeline and accelerating toward commercialization, the Group has continued to broaden its marketing channels. In addition to strengthening our established offline hospital networks, deepening partnerships with local distributors, and hosting academic conferences, we have actively expanded into online e-commerce platforms to enhance product accessibility and extend our market reach. Our ambitions extend well beyond China. During the year, we formed a strategic partnership with Kexing Biopharm to accelerate the global expansion of Bogutai®. Through this collaboration, we have granted Kexing Biopharm exclusive commercialization rights for Bogutai® in six international markets—Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico—laying a solid foundation for global growth. We expect these markets to begin contributing revenue as early as the end of 2026. At the same time, we are advancing the FDA approval process for Bogutai® in the United States, aiming for approval as early as 2027. In December, we also entered into a strategic collaboration with Wenzhou Medical University and the People’s Government of Ouhai District, Wenzhou, to foster a synergistic ‘government–university–enterprise’ model, further strengthening our capabilities in regenerative medicine. Supported by strong partnerships with local governments and leading academic institutions, we are well positioned to build a world-class biomedical ecosystem and enhance our end-to-end innovation capabilities.” About Uni-Bio Science Group Limited Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001 (Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to be the global leader in regenerative medicine, redefining how science restores and extends human life. For further information, please contact: ir@uni-bioscience.com 27/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Lebih lanjut
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint ACN Newswire

Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint

HONG KONG, March 23, 2026 - (ACN Newswire) - Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited ("CORXEL"). Under the agreement, the Company has acquired the rights to develop, manufacture, and commercialize CARDAMYST™ (etripamil) nasal spray in Greater China, including Chinese Mainland, Hong Kong, Macao and Taiwan region.Under the terms of the agreement, Everest will pay CORXEL an upfront payment of US$30 million (equivalent to approximately RMB344,895,000), as well as potential development milestone payments of up to US$20 million (equivalent to approximately RMB137,958,000). As part of this agreement, Everest will be assigned and transferred rights, interests, claims, duties, obligations and liabilities (other than certain excluded liabilities) under the Milestone License Agreement entered into by CORXEL in May 2021 and certain related ancillary agreements.CARDAMYST™ (etripamil) nasal spray is a novel, rapid-acting calcium channel blocker as administered as needed via a convenient, portable nasal spray. It offers rapid onset of action, favorable tolerability, and the potential for at-home self-administration, enhancing patient accessibility. In December 2025, CARDAMYST was approved by the U.S. Food and Drug Administration (FDA), becoming the first and only self-administered nasal spray in more than 30 years capable of converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. As a rapid-acting treatment option, CARDAMYST can be self-administered outside the emergency department or other healthcare settings, enabling patients to actively manage episodes and gain greater control over their condition. In addition to its approved indication for PSVT, etripamil nasal spray is also under clinical development for atrial fibrillation with rapid ventricular response (AFib-RVR). Phase II trials have shown encouraging results, and Phase III trials are planned, with the potential to further extend its therapeutic impact to a broader patient population.In China, the New Drug Application (NDA) for etripamil nasal spray was accepted by the National Medical Products Administration (NMPA) on January 17, 2025 and is expected to receive approval in the third quarter of 2026.PSVT is characterized by abnormalities in the heart's electrical system that cause sudden unexpected and often severely symptomatic episodes of rapid heart rate. There are currently no approved self-administered, fast-acting, non-injectable therapies for acute PSVT, leaving patients with limited treatment options beyond emergency care. Approximately 2.3 to 4 per 1,000 individuals are affected by PSVT, representing an estimated 3 to 6 million patients in China.AFib-RVR is a type of irregular heart rhythm, characterized by an irregular and elevated heart rate. Its onset is typically gradual, episodes are less likely to terminate spontaneously, and the condition tends to recur, significantly increasing the risk of thromboembolism and serious complications such as stroke and heart failure. In China, atrial fibrillation affects an estimated 1.6% of the population, representing nearly 20 million patients, and is expected to increase with an aging population. Both PSVT and AFib-RVR are associated with a loss of control and a significant psychological burden for patients.Overall, the combined patient population for PSVT and AFib-RVR exceeds 25 million, representing a significantly unmet clinical need that urgently requires more convenient and more effective treatment options.In terms of clinical data, the NDA for etripamil nasal spray was accepted by the NMPA based on data from the pivotal global Phase 3 RAPID study and the China Phase 3 JX02002 study. Both trials met their primary endpoints. Overall, the treatment emergent adverse events (TEAEs) were comparable between the etripamil and placebo groups. The FDA approval of CARDAMYST was supported by a robust clinical program that included safety data from more than 1,800 participants across more than 2,000 PSVT episodes. This included the Phase 3 RAPID trial, a global, randomized, double-blind comparison of etripamil versus placebo, published in The Lancet in 2023. The RAPID trial achieved its primary endpoint, with 64% of participants who self-administered etripamil (N=99) converting from supraventricular tachycardia (SVT) to sinus rhythm within 30 minutes compared with 31% on placebo (N=85) (HR = 2.62; p
Lebih lanjut
Xunce Technology’s Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon? ACN Newswire

Xunce Technology’s Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?

HONG KONG, Mar 27, 2026 - (ACN Newswire) - As AI accelerates into the inference era, enterprise-grade AI is achieving large-scale deployment, driving an exponential surge in Token consumption and ushering data demand into a new development stage. Against this backdrop, high-quality, structured and scenario-specific professional data has become critical for enterprises to forge core strategic competitiveness in the era of AI.As a leading provider of AI real-time data infrastructure and analysis services in China, Xunce Technology is rapidly solidifying its core position in AI data, driven by industry tailwinds, full-chain technological capabilities and diversified growth engines. Amid the unfolding landscape of the intelligent economy, this ten-year industry stalwart is entering a pivotal window for structural revaluation.Token Value Restructuring: Making Every Data Access Quantifiable and MonetizableFounded in 2016, Xunce Technology has built a full-chain technological system spanning data acquisition, cleansing, standardization, real-time computing and large- model optimization over a decade of development. With AI Data Agent at its core, the Company specializes in millisecond-level real-time data processing, serving a diversified portfolio of industries including finance, urban governance, high-end manufacturing, healthcare, robotics, satellite applications, low-altitude economy, electric power, power grids and energy.As the era of AI inference unfolds, Token is evolving from mere “fuel” to a form of “hard currency”. Maximizing the value of each individual Token has emerged as a central challenge in the large-model inference era. Today, general-purpose large models typically rely on a “computing power for precision” approach, where every inference run generates substantial wasteful Token consumption. Should inference fail, all Tokens expended in the process are lost entirely, which is a common pain-point plaguing general AI systems.By contrast, vertical AI solutions equip general large language models with an external industry “brain” powered by domain-specific data. At its core, such solutions optimize inference logic via business-aware models, enabling upfront task feasibility validation and eliminating Token waste at the source. With deep expertise in professional vertical domain data modeling, Xunce Technology leverages its extensive portfolio of high-quality, scenario-specific proprietary data to act as an “efficiency multiplier” for every Token invocation. This structure translates Token consumption into higher-precision outputs while securing maximal result certainty. Crucially, the Company is developing full-chain capabilities spanning data metering, pricing and settlement, enabling quantifiable and monetizable measurement for every data access. By elevating per-unit Token efficiency, it delivers enhanced business value to enterprise clients.Aligned with this strategy, Xunce’s platform features a “LEGO-inspired” modular architecture, enabling clients to flexibly compose modules tailored to their specific needs. This “assemble-on-demand, adapt-in-real-time” design fosters deep and long-term customer stickiness. The Company also employs a highly flexible pricing framework, with fees structured around module count, processing throughput and other key metrics. Supported by subscription, transaction-based and Token-based payment models, its pricing mechanism precisely aligns with diverse client demands.Currently, Xunce Technology is fully building a full-chain data measurement and settlement system. It is exploring pricing mechanisms tied to large model inference frequency and module usage count, allowing customers to pay for effective Tokens rather than raw computing power consumption.Inflection Point Reached, Profitability ConfirmedDriven by Token value restructuring and innovative business models, Xunce Technology has delivered robust performance and reached a historic inflection point. In H2 2025, the Company posted an adjusted net profit of RMB 50 million, achieving its first positive profitability. Meanwhile, revenue rose from RMB 197.85 million in H1 2025 to RMB 1,086.81 million in H2, representing a 449.32% quarter-on-quarter surge. Amid rapid business expansion, the Company has witnessed a substantial improvement in profitability.Explosive Revenue GrowthReturn to Profit in H2Doubled ARPU & Per Capita GrowthImproved Cash Flow & Operating Metrics+103% Y/YNarrowed by 33%+105% Y/YSignificant Improvement2025 full-year revenue YoY growth2025 full-year adjusted net loss2025 ARPU YoY growth2025 net operating cash flow+449% H/HRMB 50 million+135% Y/YAmple cash on hand in 20252025 H2 revenue HoH growth2025 H2 adjusted net profit2025 per capita revenue YoY growthAverage collection period decreased in 2025For the full year, the Company posted total operating revenue of RMB 1,284.66 million, representing a substantial year-on-year increase of 103.28% and successfully breaking the key milestone of RMB 1 billion in revenue. This signifies that the Company has evolved from an early-stage, technology-driven startup into a new era of platform-based development with scalable and replicable business models.Furthermore, the Company’s combined gross proceeds for 2025 amounted to approximately RMB 792.08 million, representing a substantial increase of 63.44% compared to approximately RMB 484.63 million in the previous year. In terms of adjusted net loss, after deducting one-off non-recurring gains and losses, the Company’s adjusted net loss for 2025 was RMB 54.84 million, representing a significant narrowing of 33% from RMB 82.37 million in 2024.Notably, the Company achieved combined gross margin of 62% in 2025, exceeding that of Cambricon (55%), a leading AI chip provider, and far outpacing general large- model developer Minimax (25.4%). This underscores its high-value strategic positioning and resilient business model in the AI data infrastructure sector.In terms of R&D investment, Xunce Technology has also maintained efficient growth conversion. In 2025, the Company’s R&D expenditure reached RMB 450.44 million, with R&D expenses accounting for 48% of revenue, driving a 105% year-on-year increase in operating revenue. For comparison, Minimax’s R&D expenditure accounted for as high as 219% of its revenue, with a revenue growth rate of 159%. Xunce achieved a comparable expansion pace with a lower R&D intensity.As revenue scale continues to expand and gross margin in new industries gradually stabilize, the Company’s short-term objective is to achieve an inflection point in adjusted net profit. Looking ahead, as the industries already deployed enter a period of margin stabilization and Token-based payment and revenue-sharing models gain accelerated traction, its net profit is poised to improve at an accelerated rate.Driven by Diversified Growth Engines, Business Structure Continuously OptimizedThe robust revenue growth is not accidental, but underpinned by Xunce Technology’s multi-dimensional, systematically structured growth framework.Accelerate cross-industry replication. The Company currently covers 9 major industries, benchmarking Palantir’s 17 industries and leaving ample room for horizontal expansion. Xunce Technology is rapidly deepening its presence in key national strategic sectors such as asset management, telecommunications, electric power, urban management, high-end manufacturing, healthcare, energy, robotics training platforms and commercial aerospace. For each new industry, the Company first completes industry-specific data accumulation over 3 to 5 years, enabling rapid replication and scaled deployment across peer customers thereafter.The business model fosters deep customer value enhancement. As customers evolve from single-module adoption to multi-module deployment, and from pilot trials to full integration into core business workflows, substantial upside potential in ARPU remains. By synergistically lifting Token invocation volume, module usage count and per-Token value, the Company will unlock a new dimension of growth.Steadily expand overseas business and establish a global layout. The Company targets raising its overseas revenue share to 10% to 15% in 2026, and will further escalate its globalization strategy during 2027 and 2028, unlocking new avenues for sustained long-term growth.Cultivate a strategic cooperative ecosystem to forge deep integration with upstream and downstream partners in computing power and algorithms. Xunce Technology is engaging in in-depth collaboration with leading domestic GPU providers and large language model enterprises to build a one-stop solution encompassing “infrastructure computing power, upper-layer applications and data governance,” further solidifying its core position in the AI data infrastructure sector. Pioneer cutting-edge applications to seize commanding heights in future industries. From robotics data platforms to commercial aerospace, low-altitude economy and power grid systems, Xunce Technology has taken the lead in extending AI infrastructure to emerging sectors with stringent demands for real-time performance and operational reliability. Such mission-critical scenarios with ultra-high requirements for data timeliness and stability serve as a rigorous validation of the Company’s technological advantages. The Company will continue to ramp up R&D investment in frontier fields, refine its technical capabilities through high-end application scenarios and unlock new high-growth, high-value growth tracks for long-term development.Evolving from Data Services to Core AI Economy Infrastructure: Building Sustainable Competitive BarriersFrom a macro perspective, the artificial intelligence data sector is witnessing a profound convergence of five defining trends: a surge in demand for real-time, secure, high-quality data in the era of AI Agent; the rise of domain-specific models elevating professional data as a critical enabler for industry-wide intelligent upgrading; standardization of data interfaces driven by next-generation AI operating systems including Open Claw, positioning Xunce Technology as a core data Token provider; Token-based payment emerging as a new paradigm for the data element market; and the implementation of data asset capitalization policies, spurring a sharp rise in enterprises’ mandatory investment in data governance.At the intersection of these five pivotal trends, Xunce Technology has established a robust fundamental logic for sustained long-term growth. The Company has evolved beyond a traditional data infrastructure provider to become a critical “connector” and “enabler” linking large models, computing power and cloud vendors. By integrating upstream models, downstream computing power and horizontal collaboration with cloud vendors, the Company delivers irreplaceable data-centric value to its enterprise clients.The Company stresses that it shares a natural upstream-downstream synergy with general large-model providers, rather than a competitive dynamic. Analogous to the deep collaboration between GPU manufacturers and model developers, the value of Xunce Technology lies in a mutually reinforcing cycle: the wider the adoption of models by its clients, the greater the opportunity for the Company to deliver services and generate incremental value for clients.Notably, in contrast to niche market players offering only isolated modules such as data cleansing or computing engines, Xunce Technology’s core differentiation lies in its full-process coverage and outcome-driven accountability. The Company provides an end-to-end solution spanning data acquisition, cleansing, standardization, modeling, real-time computing and model tuning, ensuring that final data delivered to clients is clean, accurate, real-time and accessible for model invocation at millisecond latency. Furthermore, through deep integration into clients’ private clouds or on-premises environments, the Company acts as a dedicated data steward, fostering exceptional customer stickiness and forging robust, sustainable competitive barriers.Currently, the Company’s product portfolio and solutions feature more than 300 functional modules, covering a full spectrum of scenarios from data infrastructure to upper-layer analytics applications. In 2025, its active paid clients base reached 230, with an outstanding customer retention rate of 90%. ARPU increased substantially from RMB 2.72 million in 2024 to RMB 5.59 million in 2025, representing a year-on-year growth of over 103%.As algorithms become increasingly open-source and computing power tends toward standardization, what truly sets companies apart lies in data — particularly industry data that has undergone sophisticated governance and can effectively empower large models. Backed by a decade of deep industry expertise, Xunce Technology has established a substantial and sustainable competitive barrier in this domain.ConclusionFrom an early-stage private equity tool provider to a cross-industry AI data infrastructure builder, and from a module supplier to a Token-priced core platform, Xunce Technology has remained committed to unlocking data as a scarce, strategic resource that is freely circulable, readily callable and empowered to drive high-quality decision-making.Amid the rapid emergence of new intelligent economic paradigms, the Company stands at the threshold of a fundamental structural revaluation, with the potential to enter the RMB 100-billion market cap camp. It is a competitor to none, but an indispensable partner to all. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Lebih lanjut
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy JCN Newswire

Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy

TOKYO, Mar 27, 2026 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and MSD K.K. (Headquarters: Tokyo, Representative Director: Prashant Nikam, “MSD”), a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, announced today that an application for LENVIMA® (lenvatinib), an orally available multiple receptor tyrosine kinase inhibitor (TKI) discovered by Eisai, has been submitted in Japan for the additional dosage and administration in combination with WELIREG® (belzutifan), the first-in-class oral hypoxiainducible factor-2 alpha (HIF-2α) inhibitor from MSD, for the treatment of unresectable or metastatic renal cell carcinoma that has progressed after chemotherapy.This application is based on the results of the Phase 3 LITESPARK-011 trial evaluating the dual regimen of LENVIMA plus WELIREG for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease progressed on or after treatment with anti-programmed death receptor-1 (PD-1)/ programmed death-ligand 1 (PD-L1) therapy. The data from this trial were presented at the 2026 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium in February 2026. At a pre-specified interim analysis with a median follow-up of 29.0 months (range, 19.3-49.2), the LENVIMA plus WELIREG combination therapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS), one of the primary endpoints, reducing the risk of disease progression or death by 30% (HR=0.70 [95% CI, 0.59-0.84]; p=0.00007) compared to cabozantinib. The safety profile of this combination was consistent with those reported for each agent administered as monotherapy, and no new safety signals were identified.In 2022, approximately 435,000 people worldwide were newly diagnosed with kidney cancer, and about 156,000 people died from the disease. 1 In Japan, it is estimated that roughly 21,000 people were newly diagnosed and about 7,000 died in 2022.2 RCC accounts for approximately 85% of kidney cancers3, and the five-year survival rates for patients with stage III and IV RCC have been reported as 63%–78% and 27%–28%4, respectively, indicating that the disease still has a high unmet medical needs.LENVIMA is approved in combination with KEYTRUDA ® (pembrolizumab) in Japan for the first-line treatment of unresectable or metastatic RCC. WELIREG is approved in Japan for the treatment of unresectable or metastatic RCC that has progressed following cancer chemotherapy. Additionally, supplemental New Drug Applications (sNDA) for the LENVIMA and WELIREG combination therapy for the treatment of adult patients with advanced RCC with a clear cell component following a PD-1 or PDL1 inhibitor has been accepted by the U.S. Food and Drug Administration (FDA), with a PDUFA (Prescription Drug User Fee Act) target action date set for October 4, 2026.Eisai and MSD have been collaborating through the provision of information on LENVIMA in Japan since October 2018, and will work together to expedite the maximization of contribution to patients with cancer.About LENVIMA (lenvatinib)LENVIMA, discovered and developed by Eisai, is an orally available multiple receptor tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). LENVIMA inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1- 4, the platelet derived growth factor receptor alpha (PDGFRα), KIT, and RET. In syngeneic mouse tumor models, LENVIMA decreased tumor-associated macrophages, increased activated cytotoxic T cells, and demonstrated greater antitumor activity in combination with an anti-PD-1 monoclonal antibody compared to either treatment alone. LENVIMA has been approved for the indications below.Thyroid cancer- Indication as monotherapy(Approved mainly in Japan, the United States, Europe, China and Asia)Japan: Unresectable thyroid cancerThe United States: The treatment of patients with locally recurrent or metastatic, progressive, radioiodine-refractory differentiated thyroid cancer (DTC)Europe: The treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI)Hepatocellular carcinoma- Indication as monotherapy(Approved mainly in Japan, the United States, Europe, China and Asia)Japan: Unresectable hepatocellular carcinomaThe United States: The first-line treatment of patients with unresectable hepatocellular carcinoma (HCC)Europe: The treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy- Indication in combination with KEYTRUDA (generic name: pembrolizumab) and transarterial chemoembolization (Approved in China)Thymic carcinoma- Indication as monotherapy (Approved in Japan)Japan: Unresectable thymic carcinomaRenal cell carcinoma (In Europe other than the United Kingdom, the agent was launched under the brand name Kisplyx®)- Indication in combination with everolimus(Approved mainly in the United States, Europe and Asia) The United States: The treatment of adult patients with advanced renal cell carcinoma (RCC) following one prior anti-angiogenic therapyEurope: The treatment of adult patients with advanced renal cell carcinoma following one prior vascular endothelial growth factor (VEGF) targeted therapy- Indication in combination with KEYTRUDA(Approved mainly in Japan, the United States, Europe and Asia)Japan: Radically unresectable or metastatic renal cell carcinomaThe United States: The first-line treatment of adult patients with advanced renal cell carcinomaEurope: The first-line treatment of adult patients with advanced renal cell carcinomaEndometrial carcinoma- Indication in combination with KEYTRUDA(Approved mainly in Japan, the United States, Europe and Asia)Japan: Unresectable, advanced or recurrent endometrial carcinoma that progressed after cancer chemotherapyThe United States: The treatment of patients with advanced endometrial carcinoma that is pMMR or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiationEurope: The treatment of adult patients with advanced or recurrent endometrial carcinoma (EC) who have disease progression on or following prior treatment with a platinum-containing therapy in any setting and are not candidates for curative surgery.About WELIREG (belzutifan)WELIREG, Merck & Co., Inc., Rahway, NJ, USA’s, known as MSD outside of the United States and Canada, first-in-class hypoxia-inducible factor 2 alpha (HIF-2α) inhibitor, is an orally administered small-molecule designed to reduce transcription and expression of HIF-2α target genes associated with cellular proliferation, angiogenesis and tumor growth. By inhibiting HIF-2α signaling, WELIREG aims to disrupt key pathways certain tumors may use to adapt to low-oxygen conditions, including those that help promote abnormal blood vessel formation and support tumor survival. WELIREG has demonstrated antitumor activity in certain von Hippel-Lindau (VHL) diseaseassociated tumors, renal cell carcinoma and in pheochromocytoma or paraganglioma. As part of a broader clinical program, Merck & Co., Inc., Rahway, NJ, USA continues to research WELIREG monotherapy and combination approaches for people with genitourinary, breast and gynecologic cancers across a range of treatment settings to further define where HIF-2α inhibition may provide clinical benefit and to better understand which patients are most likely to respond. WELIREG has been approved in Japan for the treatment of certain von Hippel–Lindau (VHL) disease–associated tumors, as well as for unresectable or metastatic renal cell carcinoma that has progressed after chemotherapy.LITESPARK-011 ResultsData from LITESPARK-011 (ClinicalTrials.gov, NCT04586231) were presented at the ASCO GU Symposium held in February 2026. LITESPARK-011 is a randomized, open-label Phase 3 trial (ClinicalTrials.gov, NCT04586231) evaluating WELIREG in combination with LENVIMA compared to cabozantinib for the treatment of patients with advanced clear cell RCC that has progressed on or after anti-PD-1/L1 therapy. The dual primary endpoints are progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) as assessed by blinded independent central review (BICR), and overall survival (OS). Secondary endpoints include objective response rate (ORR) per RECIST v1.1 as assessed by BICR, duration of response (DOR) per RECIST v1.1 as assessed by BICR, and safety. The trial enrolled 747 patients who were randomized to receive WELIREG (120 mg orally once daily) plus LENVIMA (20 mg orally once daily) or cabozantinib (60 mg orally once daily).At a pre-specified second interim analysis with a median follow-up of 29.0 months (range, 19.3- 49.2), WELIREG plus LENVIMA demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of PFS, reducing the risk of disease progression or death by 30% (HR=0.70 [95% CI, 0.59-0.84]; p=0.00007) compared to cabozantinib. For WELIREG plus LENVIMA, the median PFS was 14.8 months (95% CI, 11.2-16.6) versus 10.7 months (95% CI, 9.2-11.1) for cabozantinib. A trend toward improvement in overall survival (OS), the trial’s other primary endpoint, was also observed for WELIREG plus LENVIMA (HR=0.85 [95% CI, 0.68-1.05]; p=0.06075). The median OS was 34.9 months (95% CI, 27.5-NR) for WELIREG plus LENVIMA versus 27.6 months (95% CI, 24.0-31.4) for cabozantinib. The trial is continuing, and OS will be evaluated at a subsequent analysis per the clinical trial protocol. Regarding secondary endpoints, at the first interim analysis with a median follow-up of 19.6 months (range, 9.9-39.8), WELIREG plus LENVIMA met ORR, demonstrating a statistically significant improvement compared to cabozantinib. A confirmed ORR of 52.6% (95% CI, 47.3-57.7) was observed for WELIREG plus LENVIMA versus 39.6% (95% CI, 34.6-44.8) for cabozantinib. At the second interim analysis with a median follow-up of 29.0 months, the median DOR was 23.0 months (95% CI, 2.0-44.3+) for WELIREG plus LENVIMA versus 12.3 months (95% CI, 1.8+-35.9+) for cabozantinib. WELIREG plus LENVIMA was administered to 370 patients and cabozantinib was administered to 371 patients. Grade ≥3 treatment-related adverse events (TRAEs) occurred in 71.6% of patients receiving WELIREG plus LENVIMA versus 65.8% of patients receiving cabozantinib. Adverse events led to treatment discontinuation in 11.1% of patients receiving WELIREG plus LENVIMA and in 11.3% of patients receiving cabozantinib, respectively. Serious adverse events were observed in 51.6% of patients receiving WELIREG plus LENVIMA versus 43.9% of patients receiving cabozantinib, and AEs led to death in 5.4% of patients (two were treatment-related: thrombotic microangiopathy [n=1] and pneumonitis [n=1]) versus 3.2% (one was treatment-related: hemoptysis [n=1]) of patients, respectively.About the Eisai and Merck & Co., Inc., Rahway, NJ, USA Strategic CollaborationIn March 2018, Eisai and Merck & Co., Inc., Rahway, NJ, USA through an affiliate, entered into a strategic collaboration for the worldwide co-development and co-commercialization of LENVIMA. Under the agreement, the companies jointly develop, manufacture and commercialize LENVIMA, both as monotherapy and in combination with Merck & Co., Inc., Rahway, NJ, USA’s anti-PD-1 therapy, KEYTRUDA, and HIF-2α inhibitor, WELIREG.Eisai’s focus on cancerEisai acknowledges “Oncology” as one of its key strategic areas, and will continue to focus on the discovery and development of anti-cancer drugs within drug discovery domains including “microenvironment”, “protein integrity and homeostasis”, and “cell lineage and cell differentiation” under the Deep Human Biology Learning (DHBL) drug discovery and development organization. Eisai aspires to discover innovative new drugs with new targets and mechanisms of action from these domains, with the aim of contributing to the cure of cancers.6. About EisaiEisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, our continued commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), is demonstrated by our work on various activities together with global partners. For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), us.eisai.com (for U.S. headquarters: Eisai Inc.) or www.eisai.eu (for Europe, Middle East, Africa, Russia, Australia, and New Zealand headquarters: Eisai Europe Ltd.), and connect with us on X (U.S. and global), LinkedIn (for U.S. and EMEA) and Facebook (global).Merck & Co., Inc., Rahway, NJ, USA’s Focus on CancerEvery day, we follow the science as we work to discover innovations that can help patients, no matter what stage of cancer they have. As a leading oncology company, we are pursuing research where scientific opportunity and medical need converge, underpinned by our diverse pipeline of more than 25 novel mechanisms. With one of the largest clinical development programs across more than 30 tumor types, we strive to advance breakthrough science that will shape the future of oncology. By addressing barriers to clinical trial participation, screening and treatment, we work with urgency to reduce disparities and help ensure patients have access to high-quality cancer care. Our unwavering commitment is what will bring us closer to our goal of bringing life to more patients with cancer. For more information, visit https://www.merck.com/research/oncologyAbout MSDAt MSD (the name by which Merck & Co., Inc., Rahway, NJ, USA, is known outside of the United States and Canada), we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.co.jp and connect with us on Facebook, Twitter, and YouTube.Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/media/globocan/factsheets/cancers/29-kidney-fact-sheet.pdf, accessed 27 Mar 2026.Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/392-japan-fact-sheet.pdf, accessed 27 Mar 2026.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer. 2025; 2026 Version 1. Rose TL and Kim WY. Renal cell carcinoma: a review. JAMA. 2024 Sep 24;332(12):1001– 10.Media InquiriesEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120MSD K.K.Communications DivisionTatsuro MuraseTEL: +81 (0)70-8700-0112 Copyright 2026 JCN Newswire. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility JCN Newswire

Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility

TOKYO, Mar 27, 2026 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501, “Hitachi”) and MUFG Bank, Ltd. (“MUFG Bank”), a consolidated subsidiary of Mitsubishi UFJ Financial Group, Inc. (TYO: 8306, “MUFG”) today announced a new Memorandum of Understanding (MoU) to expand NextGen, their business co-creation model. Building on their collaboration launched in May 2024*1 and further developed as announced in May 2025*2 , NextGen combines Hitachi’s technology and operational expertise with MUFG’s financial capabilities to accelerate the transition to decarbonized mobility.*1 MUFG’s Business Co-Creation and Investment into UK Battery as a Service project by Hitachi ZeroCarbon May 2024*2 Hitachi ZeroCarbon and MUFG unite technology expertise with financial support to accelerate fleet electrification May 2025NextGen was initially validated through a UK pilot project with First Bus, where the parties collaborated via a special purpose vehicle (SPV) to support the procurement and operation of electrification assets under a Battery-as-a-Service model. This expanded MoU extends NextGen beyond battery-focused structures, enabling broader and more scalable deployment across additional markets outside the UK and across a wider range of asset classes. These include emobility assets such as electric vehicles and charging infrastructure, associated energy management systems, and potentially extending to energy hubs supporting industrial assets, power grids and data centers.Hitachi and MUFG Bank will also develop and scale SPV structures to finance decarbonized mobility assets for fleet and transport operators. This approach removes capital constraints and accelerates implementation, enabling operators to focus on their core transport services. From Hitachi’s side, the initiative is led by its Strategic SIB Business Unit, bringing together expertise from across Hitachi including Hitachi Energy, as ‘One Hitachi’. Hitachi will also provide managed services for asset performance and lifecycle optimization, supported by data-driven solutions from Hitachi ZeroCarbon. Through this initiative, Hitachi aims to further advance and streamline mobility and charging infrastructure operations by expanding HMAX by Hitachi, a suite of next-generation solutions that embodies Lumada 3.0, differentiated by deep domain knowledge and AI.Electrifying commercial transport at pace will require an unprecedented deployment of vehicles, charging and energy infrastructure - alongside innovative financing models to support it. Global investment in electrified transport reached around US$750 billion in 2024, making it the largest segment of the energy transition worldwide*3 - yet many fleet operators face limited access to capital and the operational complexity of transitioning at scale. Against this backdrop, Hitachi and MUFG Bank aim to expand NextGen as a repeatable model to accelerate implementation by combining structured asset financing with managed services and data-driven optimization.*3 Sources: BloombergNEF’s Energy transition Investment Trends 2025In demonstration of the expanded pipeline, Hitachi ZeroCarbon and MUFG Bank have also entered into an MoU with Boreal Norge AS and its subsidiary Boreal Buss AS, one of Norway’s primary transport operators, providing transport services across several counties and employing around 3,000 employees across its fleet, which includes over 850 buses and 35 ferries. The parties will explore how they can support Boreal’s transition planning, de-risk operations, optimize services and strengthen competitiveness as concessions evolve.Jun Taniguchi, Senior Vice President and Executive Officer, CEO of Strategic SIB Business Unit, at Hitachi, Ltd. said:“We are delighted to advance this partnership which combines Hitachi’s deep expertise in social infrastructure and digital technologies with MUFG Bank, Ltd.’s financial strength to accelerate the transition to a decarbonized society. By improving the performance of assets such as batteries and charging infrastructure through Hitachi’s digital services led by HMAX, we can truly help customers optimize the total cost of ownership. This partnership embodies our One Hitachi approach, leveraging our diverse capabilities across the Group to support our customers in achieving their net-zero ambitions.”Masakazu Osawa, Senior Managing Executive Officer Chief Executive, Japanese Corporate & Investment Banking Business Unit of MUFG Bank, Ltd., said:“Building on MUFG’s Business Co‑Creation and Investment approach, this collaboration with Hitachi aims to create value through strategic partnerships that improve society and the environment. For the global EV market, our focus is not only on strengthening Hitachi’s leading position in Battery as a Service, but also on fostering a holistic value chain — including second‑ life battery markets — that supports the acceleration of electric mobility and the achievement of 2050 net‑zero targets. Together with our partners, we are committed to co‑creating sustainable businesses that become a driving force for progress worldwide.”Nikolai Knudsmoen Utheim, Group CEO, Boreal Norge AS said:“Our priority has always been to deliver first-class transport services to our customers, whether that’s on the road, rail or over water. In exploring how we can unlock the power of electrified fleets, we can not only deliver more sustainable operations, but upgrade our infrastructure and thread technology across our entire business model for more efficient, smart transport and energy management.”About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.About MUFGMitsubishi UFJ Financial Group, Inc. (MUFG) is one of the world’s leading financial groups. Headquartered in Tokyo and with over 360 years of history, MUFG has a global network with approximately 2,000 locations in more than 40 countries. The Group has about 150,000 employees and offers services including commercial banking, trust banking, securities, credit cards, consumer finance, asset management, and leasing. The Group aims to “be the world’s most trusted financial group” through close collaboration among our operating companies and flexibly respond to all of the financial needs of our customers, serving society, and fostering shared and sustainable growth for a better world. MUFG’s shares trade on the Tokyo, Nagoya, and New York stock exchanges. For more information, visit https://www.mufg.jp/english.About BorealBoreal is a leading mobility provider, operating buses, fast ferries, passenger ferries and trams in Norway and Sweden. We remain firmly committed to our societal mission of encouraging more people to travel collectively. At the same time, we are more than public transport. As the only company operating buses, ferries, fast ferries, trams and tourism services, we deliver integrated mobility solutions and travel experiences. Although Boreal is a young company in name, its heritage extends back more than 150 years. The company has around 3,000 employees and is headquartered in Stavanger, Norway. Copyright 2026 JCN Newswire. All rights reserved. www.jcnnewswire.com
Lebih lanjut